"path_id"	"full_path_length.x"	"testable_path_length.x"	"drug_targeted_genes"	"proportion_drug_targeted"	"full_path_length.y"	"testable_path_length.y"	"aberrational_genes"	"proportion_aberrational"	"proportion_of_cohort_w_aberrational_gene_in_path"	"Num_patient_with_aberrational_gene_.s._in_path"	"count_of_aberrational_genes_in_path_cross_cohort"	"max_in_one_gene"	"min_in_one_gene"	"hyperg_p_value"	"hyperg_p_w_FDR"
"405"	"p130Cas linkage to MAPK signaling for integrins"	15	15	3	0.2	15	15	12	0.8	0.203389830508475	24	28	6	0	0.000396607883668687	0.0865112272503199
"787"	"Generic Transcription Pathway"	483	483	26	0.0538302277432712	483	483	234	0.484472049689441	0.855932203389831	101	393	23	0	0.000408809582490122	0.0876352963123073
"704"	"Neuronal System"	280	280	24	0.0857142857142857	280	280	142	0.507142857142857	0.771186440677966	91	253	7	0	0.000459109885511122	0.0967499208299931
"889"	"Integrin cell surface interactions"	66	66	2	0.0303030303030303	66	66	40	0.606060606060606	0.457627118644068	54	74	6	0	0.000478383241993896	0.0991312752766112
"829"	"NRAGE signals death through JNK"	45	45	2	0.0444444444444444	45	45	29	0.644444444444444	0.330508474576271	39	60	6	0	0.000491712548494228	0.100223010167481
"139"	"Transport of organic anions"	11	11	4	0.363636363636364	11	11	9	0.818181818181818	0.0932203389830508	11	12	3	0	0.000974141862406963	0.182258591824738
"434"	"Apoptotic execution  phase"	52	52	9	0.173076923076923	52	52	32	0.615384615384615	0.423728813559322	50	69	12	0	0.000982147752776941	0.182258591824738
"849"	"Assembly of collagen fibrils and other multimeric structures"	54	54	2	0.037037037037037	54	54	33	0.611111111111111	0.466101694915254	55	89	10	0	0.00101454610951568	0.185502113899601
"66"	"Sema3A PAK dependent Axon repulsion"	16	16	7	0.4375	16	16	12	0.75	0.203389830508475	24	28	6	0	0.00131205671319168	0.234247623127175
"539"	"PLC beta mediated events"	43	43	6	0.13953488372093	43	43	27	0.627906976744186	0.338983050847458	40	50	7	0	0.00131882523027804	0.234247623127175
"707"	"ABC-family proteins mediated transport"	36	36	3	0.0833333333333333	36	36	23	0.638888888888889	0.296610169491525	35	45	5	0	0.00179469193344572	0.299912946881152
"548"	"G-protein mediated events"	44	44	6	0.136363636363636	44	44	27	0.613636363636364	0.338983050847458	40	50	7	0	0.00221014624849569	0.331076919786898
"329"	"NCAM signaling for neurite out-growth"	70	70	16	0.228571428571429	70	70	40	0.571428571428571	0.474576271186441	56	90	7	0	0.00247924106693154	0.360088166636286
"314"	"Signalling by NGF"	287	287	69	0.240418118466899	287	287	141	0.491289198606272	0.771186440677966	91	280	20	0	0.00250341473953197	0.360088166636286
"867"	"Cell-cell junction organization"	60	60	2	0.0333333333333333	60	60	35	0.583333333333333	0.440677966101695	52	72	10	0	0.00251966101428369	0.360088166636286
"283"	"GRB2:SOS provides linkage to MAPK signaling for Integrins"	15	15	4	0.266666666666667	15	15	11	0.733333333333333	0.194915254237288	23	26	6	0	0.00261984075536725	0.370150386908225
"359"	"EGFR interacts with phospholipase C-gamma"	33	33	7	0.212121212121212	33	33	21	0.636363636363636	0.322033898305085	38	45	7	0	0.00277622826702795	0.387838707702472
"857"	"Cell junction organization"	85	85	3	0.0352941176470588	85	85	47	0.552941176470588	0.525423728813559	62	109	10	0	0.00315240023493857	0.43549665907923
"587"	"p75 NTR receptor-mediated signalling"	83	83	10	0.120481927710843	83	83	46	0.55421686746988	0.432203389830508	51	87	6	0	0.00321599629176206	0.439400081244595
"134"	"EPHB-mediated forward signaling"	41	41	15	0.365853658536585	41	41	25	0.609756097560976	0.347457627118644	41	52	7	0	0.00338521010312465	0.457492297893412
"334"	"Semaphorin interactions"	67	67	15	0.223880597014925	67	67	38	0.567164179104478	0.449152542372881	53	90	7	0	0.00364378130340626	0.4768861215872
"936"	"GABA receptor activation"	55	55	1	0.0181818181818182	55	55	32	0.581818181818182	0.347457627118644	41	59	7	0	0.00375655355944726	0.486524077746712
"310"	"Signaling by PDGF"	184	184	46	0.25	184	184	93	0.505434782608696	0.73728813559322	87	206	20	0	0.0040378484592547	0.517564246431894
"363"	"Signaling by FGFR1 fusion mutants"	19	19	4	0.210526315789474	19	19	13	0.684210526315789	0.347457627118644	41	44	20	0	0.00426587835534209	0.54104126804688
"871"	"Molecules associated with elastic fibres"	30	30	1	0.0333333333333333	30	30	19	0.633333333333333	0.220338983050847	26	29	5	0	0.00430803874941177	0.54104126804688
"23"	"EPHA-mediated growth cone collapse"	34	34	18	0.529411764705882	34	34	21	0.617647058823529	0.38135593220339	45	63	8	0	0.00482483211306817	0.58241287523799
"319"	"PLCG1 events in ERBB2 signaling"	34	34	8	0.235294117647059	34	34	21	0.617647058823529	0.322033898305085	38	45	7	0	0.00482483211306817	0.58241287523799
"738"	"Mitotic Telophase/Cytokinesis"	14	14	1	0.0714285714285714	14	14	10	0.714285714285714	0.177966101694915	21	22	7	0	0.00515986836523907	0.60522762537091
"590"	"Non-integrin membrane-ECM interactions"	42	42	5	0.119047619047619	42	42	25	0.595238095238095	0.338983050847458	40	62	10	0	0.00543277993189251	0.625438114221025
"558"	"Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell"	140	140	18	0.128571428571429	140	140	72	0.514285714285714	0.593220338983051	70	128	7	0	0.00559487685022186	0.632451108990074
"629"	"Transmission across Chemical Synapses"	201	201	22	0.109452736318408	201	201	100	0.497512437810945	0.652542372881356	77	180	7	0	0.00559543245702532	0.632451108990074
"471"	"Effects of PIP2 hydrolysis"	25	25	4	0.16	25	25	16	0.64	0.23728813559322	28	31	4	0	0.00621942863979941	0.69042809020217
"842"	"TRP channels"	25	25	1	0.04	25	25	16	0.64	0.23728813559322	28	33	5	0	0.00621942863979941	0.69042809020217
"211"	"Integrin alphaIIb beta3 signaling"	27	27	8	0.296296296296296	27	27	17	0.62962962962963	0.254237288135593	30	37	6	0	0.00671053614326123	0.738354221450017
"107"	"Signaling by VEGF"	113	113	44	0.389380530973451	113	113	59	0.52212389380531	0.567796610169492	67	123	20	0	0.0069082064133692	0.753436126118898
"407"	"DAG and IP3 signaling"	31	31	6	0.193548387096774	31	31	19	0.612903225806452	0.288135593220339	34	40	7	0	0.00747203393241636	0.798352678550258
"360"	"PLC-gamma1 signalling"	33	33	7	0.212121212121212	33	33	20	0.606060606060606	0.296610169491525	35	41	7	0	0.00775393598119933	0.816444297781761
"874"	"Cell death signalling via NRAGE, NRIF and NADE"	61	61	2	0.0327868852459016	61	61	34	0.557377049180328	0.364406779661017	43	66	6	0	0.00781425421490534	0.816444297781761
"550"	"BMAL1:CLOCK,NPAS2 activates circadian gene expression"	37	37	5	0.135135135135135	37	37	22	0.594594594594595	0.296610169491525	35	45	7	0	0.00815036322134355	0.844465095319626
"900"	"Elastic fibre formation"	41	41	1	0.024390243902439	41	41	24	0.585365853658537	0.313559322033898	37	44	5	0	0.00836153254960204	0.857123167762888
"821"	"Voltage gated Potassium channels"	43	43	2	0.0465116279069767	43	43	25	0.581395348837209	0.305084745762712	36	43	4	0	0.00841040827829542	0.857123167762888
"251"	"Signaling by FGFR in disease"	177	177	49	0.27683615819209	177	177	88	0.497175141242938	0.720338983050847	85	185	20	0	0.00872871718543289	0.879533708820505
"492"	"Syndecan interactions"	20	20	3	0.15	20	20	13	0.65	0.11864406779661	14	17	4	0	0.00884252947027431	0.879533708820505
"486"	"Platelet Adhesion to exposed collagen"	13	13	2	0.153846153846154	13	13	9	0.692307692307692	0.101694915254237	12	14	3	0	0.0100042026397618	0.979410475783588
"365"	"Loss of Nlp from mitotic centrosomes"	62	62	13	0.209677419354839	62	62	34	0.548387096774194	0.364406779661017	43	59	5	0	0.0109283460055029	1
"366"	"Loss of proteins required for interphase microtubule organizationÂ from the centrosome"	62	62	13	0.209677419354839	62	62	34	0.548387096774194	0.364406779661017	43	59	5	0	0.0109283460055029	1
"91"	"GRB7 events in ERBB2 signaling"	5	5	2	0.4	5	5	4	0.8	0.0338983050847458	4	4	1	0	0.0119249161743226	1
"94"	"NGF-independant TRKA activation"	5	5	2	0.4	5	5	4	0.8	0.0338983050847458	4	4	1	0	0.0119249161743226	1
"395"	"S6K1 signalling"	5	5	1	0.2	5	5	4	0.8	0.0508474576271186	6	6	3	0	0.0119249161743226	1
"400"	"Signaling by FGFR1 mutants"	30	30	6	0.2	30	30	18	0.6	0.38135593220339	45	51	20	0	0.0119940494192801	1
"55"	"Recycling of bile acids and salts"	15	15	7	0.466666666666667	15	15	10	0.666666666666667	0.101694915254237	12	12	2	0	0.0121449442923864	1
"839"	"G alpha (12/13) signalling events"	75	75	3	0.04	75	75	40	0.533333333333333	0.491525423728814	58	94	20	0	0.0126599146419971	1
"679"	"Netrin-1 signaling"	42	42	4	0.0952380952380952	42	42	24	0.571428571428571	0.372881355932203	44	59	8	0	0.0126685216932922	1
"99"	"VEGFA-VEGFR2 Pathway"	105	105	42	0.4	105	105	54	0.514285714285714	0.542372881355932	64	116	20	0	0.0133025235382868	1
"598"	"PKA activation in glucagon signalling"	17	17	2	0.117647058823529	17	17	11	0.647058823529412	0.186440677966102	22	24	7	0	0.0139276474267511	1
"97"	"Role of DCC in regulating apoptosis"	10	10	4	0.4	10	10	7	0.7	0.11864406779661	14	14	8	0	0.0151470867521617	1
"205"	"Netrin mediated repulsion signals"	10	10	3	0.3	10	10	7	0.7	0.152542372881356	18	20	8	0	0.0151470867521617	1
"497"	"Circadian Clock"	55	55	8	0.145454545454545	55	55	30	0.545454545454545	0.355932203389831	42	59	7	0	0.016559273131433	1
"628"	"Hemostasis"	497	497	55	0.110663983903421	497	497	227	0.456740442655936	0.991525423728814	117	533	87	0	0.0173982224439142	1
"555"	"Double-Strand Break Repair"	23	23	3	0.130434782608696	23	23	14	0.608695652173913	0.186440677966102	22	26	5	0	0.0174346066012245	1
"227"	"Downstream signal transduction"	161	161	46	0.285714285714286	161	161	79	0.490683229813665	0.694915254237288	82	173	20	0	0.0176420291933375	1
"367"	"Centrosome maturation"	72	72	15	0.208333333333333	72	72	38	0.527777777777778	0.38135593220339	45	66	5	0	0.017821623852991	1
"371"	"Recruitment of mitotic centrosome proteins and complexes"	72	72	15	0.208333333333333	72	72	38	0.527777777777778	0.38135593220339	45	66	5	0	0.017821623852991	1
"472"	"RORA activates circadian gene expression"	25	25	4	0.16	25	25	15	0.6	0.254237288135593	30	38	7	0	0.0181159713046327	1
"719"	"Nitric oxide stimulates guanylate cyclase"	25	25	2	0.08	25	25	15	0.6	0.152542372881356	18	22	5	0	0.0181159713046327	1
"809"	"GPCR downstream signaling"	966	966	46	0.0476190476190476	966	966	428	0.443064182194617	0.923728813559322	109	700	20	0	0.0181659151333401	1
"399"	"Signaling by FGFR mutants"	45	45	9	0.2	45	45	25	0.555555555555556	0.466101694915254	55	65	20	0	0.0183026648419538	1
"696"	"Assembly of the primary cilium"	179	179	16	0.0893854748603352	179	179	87	0.486033519553073	0.635593220338983	75	146	6	0	0.0184344847123799	1
"212"	"Recycling pathway of L1"	27	27	8	0.296296296296296	27	27	16	0.592592592592593	0.169491525423729	20	23	4	0	0.0186111989723836	1
"858"	"Meiosis"	85	85	3	0.0352941176470588	85	85	44	0.517647058823529	0.508474576271186	60	93	18	0	0.0189333613421379	1
"36"	"PECAM1 interactions"	12	12	6	0.5	12	12	8	0.666666666666667	0.076271186440678	9	10	2	0	0.0190477830311928	1
"258"	"Synthesis of PIPs at the plasma membrane"	33	33	9	0.272727272727273	33	33	19	0.575757575757576	0.364406779661017	43	54	20	0	0.0192471967275912	1
"753"	"Translocation of GLUT4 to the plasma membrane"	60	60	4	0.0666666666666667	60	60	32	0.533333333333333	0.398305084745763	47	68	6	0	0.0214204170768145	1
"140"	"Activation of Rac"	14	14	5	0.357142857142857	14	14	9	0.642857142857143	0.211864406779661	25	29	8	0	0.0221150383260682	1
"353"	"DCC mediated attractive signaling"	14	14	3	0.214285714285714	14	14	9	0.642857142857143	0.161016949152542	19	21	8	0	0.0221150383260682	1
"356"	"SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion"	14	14	3	0.214285714285714	14	14	9	0.642857142857143	0.186440677966102	22	27	6	0	0.0221150383260682	1
"8"	"CREB phosphorylation"	7	7	5	0.714285714285714	7	7	5	0.714285714285714	0.0423728813559322	5	5	1	0	0.0222521303436256	1
"380"	"Phospholipase C-mediated cascade"	54	54	11	0.203703703703704	54	54	29	0.537037037037037	0.372881355932203	44	54	7	0	0.023329952827609	1
"570"	"PKA activation"	16	16	2	0.125	16	16	10	0.625	0.169491525423729	20	22	7	0	0.0244687973954694	1
"765"	"Trafficking of GluR2-containing AMPA receptors"	16	16	1	0.0625	16	16	10	0.625	0.127118644067797	15	16	3	0	0.0244687973954694	1
"215"	"Signaling by ERBB2"	163	163	48	0.294478527607362	163	163	79	0.484662576687117	0.669491525423729	79	167	20	0	0.0249099583464045	1
"340"	"Tie2 Signaling"	18	18	4	0.222222222222222	18	18	11	0.611111111111111	0.296610169491525	35	39	20	0	0.026232808679745	1
"441"	"Activation of SMO"	18	18	3	0.166666666666667	18	18	11	0.611111111111111	0.127118644067797	15	16	2	0	0.026232808679745	1
"626"	"Synthesis of PIPs at the Golgi membrane"	18	18	2	0.111111111111111	18	18	11	0.611111111111111	0.135593220338983	16	18	5	0	0.026232808679745	1
"293"	"Signaling by EGFR"	179	179	46	0.256983240223464	179	179	86	0.480446927374302	0.703389830508475	83	177	20	0	0.0264695098273917	1
"294"	"Signaling by Overexpressed Wild-Type EGFR in Cancer"	179	179	46	0.256983240223464	179	179	86	0.480446927374302	0.703389830508475	83	177	20	0	0.0264695098273917	1
"58"	"CTLA4 inhibitory signaling"	22	22	10	0.454545454545455	22	22	13	0.590909090909091	0.135593220338983	16	17	2	0	0.0284099966757224	1
"5"	"AKT-mediated inactivation of FOXO1A"	4	4	3	0.75	4	4	3	0.75	0.0423728813559322	5	5	2	0	0.0289285418770859	1
"305"	"Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes"	4	4	1	0.25	4	4	3	0.75	0.0338983050847458	4	4	2	0	0.0289285418770859	1
"306"	"Processing of DNA ends prior to end rejoining"	4	4	1	0.25	4	4	3	0.75	0.0677966101694915	8	8	5	0	0.0289285418770859	1
"458"	"REV-ERBA represses gene expression"	24	24	4	0.166666666666667	24	24	14	0.583333333333333	0.245762711864407	29	36	7	0	0.0289886442713665	1
"480"	"Anchoring of the basal body to the plasma membrane"	89	89	14	0.157303370786517	89	89	45	0.50561797752809	0.440677966101695	52	78	5	0	0.0292866657647484	1
"408"	"CaM pathway"	26	26	5	0.192307692307692	26	26	15	0.576923076923077	0.228813559322034	27	31	7	0	0.0293124229233472	1
"409"	"Calmodulin induced events"	26	26	5	0.192307692307692	26	26	15	0.576923076923077	0.228813559322034	27	31	7	0	0.0293124229233472	1
"725"	"EGFR downregulation"	26	26	2	0.0769230769230769	26	26	15	0.576923076923077	0.169491525423729	20	22	3	0	0.0293124229233472	1
"727"	"Ligand-gated ion channel transport"	26	26	2	0.0769230769230769	26	26	15	0.576923076923077	0.203389830508475	24	30	5	0	0.0293124229233472	1
"447"	"Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity"	30	30	5	0.166666666666667	30	30	17	0.566666666666667	0.177966101694915	21	25	3	0	0.0293812952818298	1
"466"	"Trafficking of AMPA receptors"	30	30	5	0.166666666666667	30	30	17	0.566666666666667	0.177966101694915	21	25	3	0	0.0293812952818298	1
"63"	"Nef and signal transduction"	9	9	4	0.444444444444444	9	9	6	0.666666666666667	0.144067796610169	17	18	6	0	0.029965767152119	1
"174"	"Regulation of gene expression by Hypoxia-inducible Factor"	9	9	3	0.333333333333333	9	9	6	0.666666666666667	0.144067796610169	17	18	7	0	0.029965767152119	1
"338"	"S6K1-mediated signalling"	9	9	2	0.222222222222222	9	9	6	0.666666666666667	0.0847457627118644	10	10	3	0	0.029965767152119	1
"221"	"Signaling by FGFR"	162	162	47	0.290123456790123	162	162	78	0.481481481481481	0.669491525423729	79	165	20	0	0.0304835978099591	1
"214"	"Downstream signaling of activated FGFR"	149	149	44	0.295302013422819	149	149	72	0.483221476510067	0.669491525423729	79	158	20	0	0.0324887651451737	1
"406"	"PI Metabolism"	51	51	10	0.196078431372549	51	51	27	0.529411764705882	0.406779661016949	48	67	20	0	0.0334972339486861	1
"798"	"Platelet homeostasis"	79	79	4	0.0506329113924051	79	79	40	0.506329113924051	0.415254237288136	49	67	6	0	0.0354013778477573	1
"426"	"mTORC1-mediated signalling"	11	11	2	0.181818181818182	11	11	7	0.636363636363636	0.0932203389830508	11	11	3	0	0.0355055152769685	1
"694"	"Tryptophan catabolism"	11	11	1	0.0909090909090909	11	11	7	0.636363636363636	0.0847457627118644	10	10	3	0	0.0355055152769685	1
"289"	"Signaling by EGFR in Cancer"	181	181	47	0.259668508287293	181	181	86	0.475138121546961	0.703389830508475	83	177	20	0	0.0358955890447645	1
"290"	"Signaling by EGFRvIII in Cancer"	181	181	47	0.259668508287293	181	181	86	0.475138121546961	0.703389830508475	83	177	20	0	0.0358955890447645	1
"291"	"Signaling by Ligand-Responsive EGFR Variants in Cancer"	181	181	47	0.259668508287293	181	181	86	0.475138121546961	0.703389830508475	83	177	20	0	0.0358955890447645	1
"75"	"Interleukin-3, 5 and GM-CSF signaling"	45	45	19	0.422222222222222	45	45	24	0.533333333333333	0.389830508474576	46	58	20	0	0.0366529582076582	1
"927"	"Potassium Channels"	99	99	2	0.0202020202020202	99	99	49	0.494949494949495	0.457627118644068	54	79	4	0	0.0383427149628053	1
"111"	"Downregulation of ERBB2:ERBB3 signaling"	13	13	5	0.384615384615385	13	13	8	0.615384615384615	0.101694915254237	12	12	2	0	0.039395838911913	1
"846"	"SLC-mediated transmembrane transport"	259	259	10	0.0386100386100386	259	259	120	0.463320463320463	0.728813559322034	86	184	5	0	0.0402714363129848	1
"312"	"Platelet Aggregation (Plug Formation)"	37	37	9	0.243243243243243	37	37	20	0.540540540540541	0.288135593220339	34	41	6	0	0.0408141706172975	1
"770"	"Response to elevated platelet cytosolic Ca2+"	84	84	5	0.0595238095238095	84	84	42	0.5	0.576271186440678	68	118	47	0	0.0409635757860343	1
"282"	"Constitutive Signaling by EGFRvIII"	15	15	4	0.266666666666667	15	15	9	0.6	0.296610169491525	35	39	20	0	0.0420552263934316	1
"595"	"Homologous Recombination Repair"	17	17	2	0.117647058823529	17	17	10	0.588235294117647	0.135593220338983	16	17	4	0	0.0437942390047863	1
"596"	"Homologous recombination repair of replication-independent double-strand breaks"	17	17	2	0.117647058823529	17	17	10	0.588235294117647	0.135593220338983	16	17	4	0	0.0437942390047863	1
"599"	"PKA-mediated phosphorylation of CREB"	17	17	2	0.117647058823529	17	17	10	0.588235294117647	0.169491525423729	20	22	7	0	0.0437942390047863	1
"429"	"Platelet activation, signaling and aggregation"	221	221	39	0.176470588235294	221	221	103	0.46606334841629	0.745762711864407	88	234	47	0	0.0442026747321639	1
"362"	"Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants"	19	19	4	0.210526315789474	19	19	11	0.578947368421053	0.322033898305085	38	42	20	0	0.0448405233920561	1
"851"	"Kinesins"	27	27	1	0.037037037037037	27	27	15	0.555555555555556	0.23728813559322	28	30	4	0	0.0448778395792944	1
"49"	"Signal transduction by L1"	21	21	10	0.476190476190476	21	21	12	0.571428571428571	0.144067796610169	17	20	5	0	0.0453617786544952	1
"2"	"RSK activation"	6	6	6	1	6	6	4	0.666666666666667	0.0338983050847458	4	4	1	0	0.0469756630989804	1
"161"	"Activation of TRKA receptors"	6	6	2	0.333333333333333	6	6	4	0.666666666666667	0.0338983050847458	4	4	1	0	0.0469756630989804	1
"169"	"Klotho-mediated ligand binding"	6	6	2	0.333333333333333	6	6	4	0.666666666666667	0.0508474576271186	6	6	2	0	0.0469756630989804	1
"454"	"Nonhomologous End-joining (NHEJ)"	6	6	1	0.166666666666667	6	6	4	0.666666666666667	0.076271186440678	9	9	5	0	0.0469756630989804	1
"224"	"NGF signalling via TRKA from the plasma membrane"	206	206	59	0.286407766990291	206	206	96	0.466019417475728	0.694915254237288	82	193	20	0	0.0497665484085748	1
"368"	"FBXW7 Mutants and NOTCH1 in Cancer"	72	72	15	0.208333333333333	72	72	36	0.5	0.449152542372881	53	89	23	0	0.0518753142262572	1
"373"	"Signaling by NOTCH1"	72	72	15	0.208333333333333	72	72	36	0.5	0.449152542372881	53	89	23	0	0.0518753142262572	1
"374"	"Signaling by NOTCH1 HD Domain Mutants in Cancer"	72	72	15	0.208333333333333	72	72	36	0.5	0.449152542372881	53	89	23	0	0.0518753142262572	1
"375"	"Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer"	72	72	15	0.208333333333333	72	72	36	0.5	0.449152542372881	53	89	23	0	0.0518753142262572	1
"376"	"Signaling by NOTCH1 PEST Domain Mutants in Cancer"	72	72	15	0.208333333333333	72	72	36	0.5	0.449152542372881	53	89	23	0	0.0518753142262572	1
"377"	"Signaling by NOTCH1 in Cancer"	72	72	15	0.208333333333333	72	72	36	0.5	0.449152542372881	53	89	23	0	0.0518753142262572	1
"378"	"Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant"	72	72	15	0.208333333333333	72	72	36	0.5	0.449152542372881	53	89	23	0	0.0518753142262572	1
"859"	"Pre-NOTCH Expression and Processing"	57	57	2	0.0350877192982456	57	57	29	0.508771929824561	0.864406779661017	102	167	87	0	0.0539103503553848	1
"562"	"Activation of gene expression by SREBF (SREBP)"	40	40	5	0.125	40	40	21	0.525	0.305084745762712	36	42	7	0	0.054741840266006	1
"563"	"ChREBP activates metabolic gene expression"	8	8	1	0.125	8	8	5	0.625	0.0932203389830508	11	12	6	0	0.0579251657679802	1
"577"	"Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)"	8	8	1	0.125	8	8	5	0.625	0.0593220338983051	7	7	2	0	0.0579251657679802	1
"51"	"CD28 co-stimulation"	32	32	15	0.46875	32	32	17	0.53125	0.347457627118644	41	49	20	0	0.0619848655010995	1
"69"	"GPVI-mediated activation cascade"	49	49	21	0.428571428571429	49	49	25	0.510204081632653	0.38135593220339	45	61	20	0	0.0628573260736398	1
"834"	"Chromatin modifying enzymes"	208	208	9	0.0432692307692308	208	208	96	0.461538461538462	0.686440677966102	81	196	15	0	0.0639023436564432	1
"835"	"Chromatin organization"	208	208	9	0.0432692307692308	208	208	96	0.461538461538462	0.686440677966102	81	196	15	0	0.0639023436564432	1
"767"	"Signaling by GPCR"	1078	1078	66	0.0612244897959184	1078	1078	467	0.433209647495362	0.940677966101695	111	757	20	0	0.0642340123020917	1
"777"	"Integration of energy metabolism"	104	104	6	0.0576923076923077	104	104	50	0.480769230769231	0.491525423728814	58	89	7	0	0.0645240859618618	1
"389"	"GP1b-IX-V activation signalling"	10	10	2	0.2	10	10	6	0.6	0.101694915254237	12	13	4	0	0.0645426880853528	1
"208"	"NOTCH1 Intracellular Domain Regulates Transcription"	47	47	14	0.297872340425532	47	47	24	0.51063829787234	0.415254237288136	49	74	23	0	0.0653135302688947	1
"352"	"Ca-dependent events"	28	28	6	0.214285714285714	28	28	15	0.535714285714286	0.228813559322034	27	31	7	0	0.0654747914983029	1
"541"	"Signaling by NOTCH"	122	122	17	0.139344262295082	122	122	58	0.475409836065574	0.889830508474576	105	212	87	0	0.0655694144578712	1
"419"	"Cytochrome P450 - arranged by substrate type"	60	60	11	0.183333333333333	60	60	30	0.5	0.271186440677966	32	42	4	0	0.0659645087481483	1
"31"	"CD28 dependent Vav1 pathway"	12	12	6	0.5	12	12	7	0.583333333333333	0.110169491525424	13	13	5	0	0.0684209797685198	1
"452"	"Inhibition of replication initiation of damaged DNA by RB1/E2F1"	12	12	2	0.166666666666667	12	12	7	0.583333333333333	0.0593220338983051	7	7	1	0	0.0684209797685198	1
"431"	"Regulation of PLK1 Activity at G2/M Transition"	80	80	14	0.175	80	80	39	0.4875	0.449152542372881	53	73	9	0	0.0697504189048821	1
"332"	"Extrinsic Pathway"	22	22	5	0.227272727272727	22	22	12	0.545454545454545	0.254237288135593	30	31	12	0	0.0698476859571671	1
"929"	"Glycogen storage diseases"	257	257	5	0.0194552529182879	257	257	117	0.455252918287938	0.745762711864407	88	216	12	0	0.0699396822422496	1
"930"	"Metabolism of carbohydrates"	257	257	5	0.0194552529182879	257	257	117	0.455252918287938	0.745762711864407	88	216	12	0	0.0699396822422496	1
"931"	"Myoclonic epilepsy of Lafora"	257	257	5	0.0194552529182879	257	257	117	0.455252918287938	0.745762711864407	88	216	12	0	0.0699396822422496	1
"166"	"GABA A (rho) receptor activation"	3	3	1	0.333333333333333	3	3	2	0.666666666666667	0.0169491525423729	2	2	1	0	0.0701643616656317	1
"170"	"Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha"	3	3	1	0.333333333333333	3	3	2	0.666666666666667	0.0169491525423729	2	2	1	0	0.0701643616656317	1
"176"	"Signalling to STAT3"	3	3	1	0.333333333333333	3	3	2	0.666666666666667	0.0254237288135593	3	3	2	0	0.0701643616656317	1
"401"	"Signaling by Hippo"	20	20	4	0.2	20	20	11	0.55	0.11864406779661	14	17	3	0	0.070827033014918	1
"404"	"Xenobiotics"	20	20	4	0.2	20	20	11	0.55	0.0932203389830508	11	12	2	0	0.070827033014918	1
"16"	"Regulation of KIT signaling"	16	16	9	0.5625	16	16	9	0.5625	0.0847457627118644	10	11	2	0	0.0713659413900354	1
"298"	"CRMPs in Sema3A signaling"	16	16	4	0.25	16	16	9	0.5625	0.161016949152542	19	20	6	0	0.0713659413900354	1
"417"	"TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)"	16	16	3	0.1875	16	16	9	0.5625	0.0932203389830508	11	11	2	0	0.0713659413900354	1
"38"	"Regulation of signaling by CBL"	18	18	9	0.5	18	18	10	0.555555555555556	0.228813559322034	27	31	20	0	0.071390772372708	1
"622"	"Norepinephrine Neurotransmitter Release Cycle"	18	18	2	0.111111111111111	18	18	10	0.555555555555556	0.161016949152542	19	24	5	0	0.071390772372708	1
"627"	"cGMP effects"	18	18	2	0.111111111111111	18	18	10	0.555555555555556	0.110169491525424	13	17	5	0	0.071390772372708	1
"720"	"Degradation of the extracellular matrix"	89	89	7	0.0786516853932584	89	89	43	0.48314606741573	0.415254237288136	49	72	6	0	0.0715832998819402	1
"80"	"Activation of NMDA receptor upon glutamate binding and postsynaptic events"	39	39	16	0.41025641025641	39	39	20	0.512820512820513	0.322033898305085	38	48	7	0	0.0760733812527954	1
"430"	"G2/M Transition"	114	114	20	0.175438596491228	114	114	54	0.473684210526316	0.533898305084746	63	99	9	0	0.0766826693049816	1
"700"	"Orphan transporters"	114	114	10	0.087719298245614	114	114	54	0.473684210526316	0.516949152542373	61	100	7	0	0.0766826693049816	1
"195"	"EPH-Ephrin signaling"	94	94	29	0.308510638297872	94	94	45	0.478723404255319	0.567796610169492	67	114	8	0	0.0788988758476934	1
"383"	"Bile acid and bile salt metabolism"	35	35	7	0.2	35	35	18	0.514285714285714	0.169491525423729	20	24	3	0	0.0820178634804521	1
"156"	"Signaling by SCF-KIT"	144	144	49	0.340277777777778	144	144	67	0.465277777777778	0.661016949152542	78	142	20	0	0.0837946436179151	1
"330"	"Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants"	57	57	13	0.228070175438596	57	57	28	0.491228070175439	0.415254237288136	49	79	23	0	0.0898053411358606	1
"331"	"Constitutive Signaling by NOTCH1 PEST Domain Mutants"	57	57	13	0.228070175438596	57	57	28	0.491228070175439	0.415254237288136	49	79	23	0	0.0898053411358606	1
"435"	"CDO in myogenesis"	29	29	5	0.172413793103448	29	29	15	0.517241379310345	0.23728813559322	28	33	8	0	0.0915625829251363	1
"437"	"Myogenesis"	29	29	5	0.172413793103448	29	29	15	0.517241379310345	0.23728813559322	28	33	8	0	0.0915625829251363	1
"901"	"Triglyceride Biosynthesis"	42	42	1	0.0238095238095238	42	42	21	0.5	0.245762711864407	29	35	6	0	0.0955458008150221	1
"1"	"Abacavir transmembrane transport"	5	5	5	1	5	5	3	0.6	0.0338983050847458	4	4	2	0	0.0969430446881394	1
"88"	"Activation of caspases through apoptosome-mediated cleavage"	5	5	2	0.4	5	5	3	0.6	0.0423728813559322	5	5	3	0	0.0969430446881394	1
"90"	"Cytochrome c-mediated apoptotic response"	5	5	2	0.4	5	5	3	0.6	0.0423728813559322	5	5	3	0	0.0969430446881394	1
"95"	"PKA-mediated phosphorylation of key metabolic factors"	5	5	2	0.4	5	5	3	0.6	0.0254237288135593	3	3	1	0	0.0969430446881394	1
"385"	"FGFR1b ligand binding and activation"	5	5	1	0.2	5	5	3	0.6	0.0254237288135593	3	4	2	0	0.0969430446881394	1
"391"	"Nicotinamide salvaging"	5	5	1	0.2	5	5	3	0.6	0.0338983050847458	4	4	2	0	0.0969430446881394	1
"412"	"Signaling by Hedgehog"	136	136	26	0.191176470588235	136	136	63	0.463235294117647	0.508474576271186	60	106	7	0	0.0972911085386388	1
"682"	"Regulation of cholesterol biosynthesis by SREBP (SREBF)"	53	53	5	0.0943396226415094	53	53	26	0.490566037735849	0.322033898305085	38	49	7	0	0.0978163890643168	1
"436"	"Mitotic G2-G2/M phases"	116	116	20	0.172413793103448	116	116	54	0.46551724137931	0.533898305084746	63	99	9	0	0.103717401976385	1
"240"	"DAP12 signaling"	164	164	46	0.280487804878049	164	164	75	0.457317073170732	0.669491525423729	79	166	20	0	0.104586284940697	1
"114"	"CD28 dependent PI3K/Akt signaling"	21	21	8	0.380952380952381	21	21	11	0.523809523809524	0.288135593220339	34	38	20	0	0.104780705495482	1
"701"	"Opioid Signalling"	80	80	7	0.0875	80	80	38	0.475	0.406779661016949	48	64	7	0	0.105232896054216	1
"788"	"Glucuronidation"	19	19	1	0.0526315789473684	19	19	10	0.526315789473684	0.152542372881356	18	20	5	0	0.107897364721104	1
"226"	"CREB phosphorylation through the activation of Adenylate Cyclase"	7	7	2	0.285714285714286	7	7	4	0.571428571428571	0.076271186440678	9	9	4	0	0.108784494987367	1
"502"	"Homologous DNA pairing and strand exchange"	7	7	1	0.142857142857143	7	7	4	0.571428571428571	0.0508474576271186	6	6	2	0	0.108784494987367	1
"320"	"Ras activation uopn Ca2+ infux through NMDA receptor"	17	17	4	0.235294117647059	17	17	9	0.529411764705882	0.194915254237288	23	27	7	0	0.110754087654677	1
"321"	"Unblocking of NMDA receptor, glutamate binding and activation"	17	17	4	0.235294117647059	17	17	9	0.529411764705882	0.152542372881356	18	22	4	0	0.110754087654677	1
"592"	"Beta-catenin phosphorylation cascade"	17	17	2	0.117647058823529	17	17	9	0.529411764705882	0.110169491525424	13	13	3	0	0.110754087654677	1
"552"	"Fatty acids"	15	15	2	0.133333333333333	15	15	8	0.533333333333333	0.0932203389830508	11	14	4	0	0.113170360325937	1
"553"	"Prolactin receptor signaling"	15	15	2	0.133333333333333	15	15	8	0.533333333333333	0.0932203389830508	11	12	2	0	0.113170360325937	1
"61"	"EGFR Transactivation by Gastrin"	9	9	4	0.444444444444444	9	9	5	0.555555555555556	0.110169491525424	13	13	7	0	0.113843962999703	1
"59"	"Purine ribonucleoside monophosphate biosynthesis"	11	11	5	0.454545454545455	11	11	6	0.545454545454545	0.0593220338983051	7	7	2	0	0.115357740500025	1
"138"	"Interleukin-7 signaling"	11	11	4	0.363636363636364	11	11	6	0.545454545454545	0.101694915254237	12	13	3	0	0.115357740500025	1
"254"	"Condensation of Prometaphase Chromosomes"	11	11	3	0.272727272727273	11	11	6	0.545454545454545	0.0677966101694915	8	8	2	0	0.115357740500025	1
"423"	"Import of palmitoyl-CoA into the mitochondrial matrix"	11	11	2	0.181818181818182	11	11	6	0.545454545454545	0.110169491525424	13	13	6	0	0.115357740500025	1
"571"	"Regulation of beta-cell development"	32	32	4	0.125	32	32	16	0.5	0.338983050847458	40	42	23	0	0.118142328639053	1
"866"	"Activated NOTCH1 Transmits Signal to the Nucleus"	30	30	1	0.0333333333333333	30	30	15	0.5	0.305084745762712	36	41	23	0	0.123337683487587	1
"104"	"Interleukin receptor SHC signaling"	28	28	11	0.392857142857143	28	28	14	0.5	0.330508474576271	39	46	20	0	0.128783274810852	1
"354"	"PKB-mediated events"	28	28	6	0.214285714285714	28	28	14	0.5	0.144067796610169	17	19	3	0	0.128783274810852	1
"797"	"Platelet degranulation"	79	79	4	0.0506329113924051	79	79	37	0.468354430379747	0.567796610169492	67	113	47	0	0.129939139528478	1
"537"	"Nuclear Envelope Breakdown"	50	50	7	0.14	50	50	24	0.48	0.26271186440678	31	36	4	0	0.132431726545964	1
"485"	"Nuclear signaling by ERBB4"	39	39	6	0.153846153846154	39	39	19	0.487179487179487	0.220338983050847	26	31	6	0	0.133297271456824	1
"117"	"EPH-ephrin mediated repulsion of cells"	48	48	18	0.375	48	48	23	0.479166666666667	0.355932203389831	42	58	8	0	0.138570769571742	1
"372"	"Sema4D induced cell migration and growth-cone collapse"	24	24	5	0.208333333333333	24	24	12	0.5	0.203389830508475	24	30	6	0	0.140459751646499	1
"630"	"G alpha (z) signalling events"	46	46	5	0.108695652173913	46	46	22	0.478260869565217	0.245762711864407	29	35	7	0	0.145061310554201	1
"57"	"Post NMDA receptor activation events"	35	35	16	0.457142857142857	35	35	17	0.485714285714286	0.288135593220339	34	40	7	0	0.146189231420835	1
"799"	"Dual incision reaction in GG-NER"	20	20	1	0.05	20	20	10	0.5	0.135593220338983	16	18	4	0	0.153205547917554	1
"801"	"Formation of incision complex in GG-NER"	20	20	1	0.05	20	20	10	0.5	0.135593220338983	16	18	4	0	0.153205547917554	1
"585"	"Nuclear Pore Complex (NPC) Disassembly"	33	33	4	0.121212121212121	33	33	16	0.484848484848485	0.194915254237288	23	27	4	0	0.153225039111702	1
"239"	"PI3K/AKT activation"	103	103	29	0.281553398058252	103	103	47	0.456310679611651	0.559322033898305	66	104	20	0	0.156371395533132	1
"814"	"Neurotransmitter Release Cycle"	42	42	2	0.0476190476190476	42	42	20	0.476190476190476	0.245762711864407	29	39	5	0	0.159214031694192	1
"955"	"Transport of inorganic cations/anions and amino acids/oligopeptides"	94	94	1	0.0106382978723404	94	94	43	0.457446808510638	0.474576271186441	56	71	5	0	0.159707361446348	1
"257"	"Signaling by ERBB4"	154	154	42	0.272727272727273	154	154	69	0.448051948051948	0.644067796610169	76	142	20	0	0.16170148561674	1
"568"	"Metabolism of Angiotensinogen to Angiotensins"	16	16	2	0.125	16	16	8	0.5	0.144067796610169	17	19	5	0	0.16691889895781	1
"764"	"TRAF6 mediated induction of TAK1 complex"	16	16	1	0.0625	16	16	8	0.5	0.110169491525424	13	14	4	0	0.16691889895781	1
"658"	"SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription"	29	29	3	0.103448275862069	29	29	14	0.482758620689655	0.152542372881356	18	20	4	0	0.168662587545547	1
"938"	"DNA Damage/Telomere Stress Induced Senescence"	58	58	1	0.0172413793103448	58	58	27	0.46551724137931	0.872881355932203	103	122	87	0	0.169190471544043	1
"34"	"Mitotic Metaphase/Anaphase Transition"	2	2	1	0.5	2	2	1	0.5	0.00847457627118644	1	1	1	0	0.170147461903084	1
"37"	"Regulation of PAK-2p34 activity by PS-GAP/RHG10"	2	2	1	0.5	2	2	1	0.5	0.00847457627118644	1	1	1	0	0.170147461903084	1
"40"	"Stimulation of the cell death response by PAK-2p34"	2	2	1	0.5	2	2	1	0.5	0.00847457627118644	1	1	1	0	0.170147461903084	1
"41"	"TRKA activation by NGF"	2	2	1	0.5	2	2	1	0.5	0.00847457627118644	1	1	1	0	0.170147461903084	1
"60"	"CREB phosphorylation through the activation of Ras"	27	27	12	0.444444444444444	27	27	13	0.481481481481481	0.211864406779661	25	31	7	0	0.177156346719258	1
"339"	"Sema4D in semaphorin signaling"	27	27	6	0.222222222222222	27	27	13	0.481481481481481	0.23728813559322	28	35	6	0	0.177156346719258	1
"341"	"mTOR signalling"	27	27	6	0.222222222222222	27	27	13	0.481481481481481	0.135593220338983	16	18	3	0	0.177156346719258	1
"710"	"Miscellaneous substrates"	12	12	1	0.0833333333333333	12	12	6	0.5	0.0847457627118644	10	11	4	0	0.181069205524133	1
"712"	"Vitamin B5 (pantothenate) metabolism"	12	12	1	0.0833333333333333	12	12	6	0.5	0.0593220338983051	7	7	2	0	0.181069205524133	1
"381"	"Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"	45	45	9	0.2	45	45	21	0.466666666666667	0.228813559322034	27	32	4	0	0.18584748405302	1
"387"	"G0 and Early G1"	25	25	5	0.2	25	25	12	0.48	0.135593220338983	16	17	4	0	0.186241165096806	1
"28"	"Abacavir transport and metabolism"	10	10	5	0.5	10	10	5	0.5	0.0508474576271186	6	6	2	0	0.187795875371228	1
"659"	"Acetylcholine regulates insulin secretion"	10	10	1	0.1	10	10	5	0.5	0.0423728813559322	5	6	2	0	0.187795875371228	1
"666"	"IRAK2 mediated activation of TAK1 complex"	10	10	1	0.1	10	10	5	0.5	0.0508474576271186	6	6	2	0	0.187795875371228	1
"667"	"IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation"	10	10	1	0.1	10	10	5	0.5	0.0508474576271186	6	6	2	0	0.187795875371228	1
"669"	"MASTL Facilitates Mitotic Progression"	10	10	1	0.1	10	10	5	0.5	0.0508474576271186	6	6	2	0	0.187795875371228	1
"671"	"Purine catabolism"	10	10	1	0.1	10	10	5	0.5	0.0593220338983051	7	7	3	0	0.187795875371228	1
"845"	"Regulation of insulin secretion"	77	77	3	0.038961038961039	77	77	35	0.454545454545455	0.347457627118644	41	58	5	0	0.192001083365874	1
"292"	"DAP12 interactions"	179	179	46	0.256983240223464	179	179	79	0.441340782122905	0.694915254237288	82	171	20	0	0.192096698938335	1
"242"	"PI-3K cascade"	100	100	28	0.28	100	100	45	0.45	0.550847457627119	65	102	20	0	0.192219287055831	1
"243"	"PI3K events in ERBB2 signaling"	100	100	28	0.28	100	100	45	0.45	0.550847457627119	65	102	20	0	0.192219287055831	1
"244"	"PI3K events in ERBB4 signaling"	100	100	28	0.28	100	100	45	0.45	0.550847457627119	65	102	20	0	0.192219287055831	1
"245"	"PI3K/AKT Signaling in Cancer"	100	100	28	0.28	100	100	45	0.45	0.550847457627119	65	102	20	0	0.192219287055831	1
"246"	"PIP3 activates AKT signaling"	100	100	28	0.28	100	100	45	0.45	0.550847457627119	65	102	20	0	0.192219287055831	1
"42"	"VEGF binds to VEGFR leading to receptor dimerization"	8	8	4	0.5	8	8	4	0.5	0.076271186440678	9	9	4	0	0.193550043686345	1
"43"	"VEGF ligand-receptor interactions"	8	8	4	0.5	8	8	4	0.5	0.076271186440678	9	9	4	0	0.193550043686345	1
"120"	"Glucocorticoid biosynthesis"	8	8	3	0.375	8	8	4	0.5	0.0423728813559322	5	5	2	0	0.193550043686345	1
"122"	"Negative regulation of the PI3K/AKT network"	8	8	3	0.375	8	8	4	0.5	0.076271186440678	9	10	3	0	0.193550043686345	1
"124"	"Organic cation transport"	8	8	3	0.375	8	8	4	0.5	0.0593220338983051	7	7	3	0	0.193550043686345	1
"129"	"WNT mediated activation of DVL"	8	8	3	0.375	8	8	4	0.5	0.0593220338983051	7	7	3	0	0.193550043686345	1
"301"	"HuR stabilizes mRNA"	8	8	2	0.25	8	8	4	0.5	0.0508474576271186	6	6	3	0	0.193550043686345	1
"565"	"Downregulation of ERBB4 signaling"	8	8	1	0.125	8	8	4	0.5	0.0932203389830508	11	11	6	0	0.193550043686345	1
"576"	"Synthesis of PG"	8	8	1	0.125	8	8	4	0.5	0.0338983050847458	4	4	1	0	0.193550043686345	1
"307"	"Proton/oligonucleotide cotransporters"	4	4	1	0.25	4	4	2	0.5	0.0169491525423729	2	2	1	0	0.193871821031269	1
"309"	"SHC activation"	4	4	1	0.25	4	4	2	0.5	0.0169491525423729	2	2	1	0	0.193871821031269	1
"164"	"FGFR2b ligand binding and activation"	6	6	2	0.333333333333333	6	6	3	0.5	0.0423728813559322	5	5	2	0	0.196877807866458	1
"180"	"Uptake and function of diphtheria toxin"	6	6	2	0.333333333333333	6	6	3	0.5	0.0338983050847458	4	4	2	0	0.196877807866458	1
"451"	"IRS activation"	6	6	1	0.166666666666667	6	6	3	0.5	0.0254237288135593	3	3	1	0	0.196877807866458	1
"453"	"Mineralocorticoid biosynthesis"	6	6	1	0.166666666666667	6	6	3	0.5	0.0254237288135593	3	3	1	0	0.196877807866458	1
"456"	"Presynaptic phase of homologous DNA pairing and strand exchange"	6	6	1	0.166666666666667	6	6	3	0.5	0.0423728813559322	5	5	2	0	0.196877807866458	1
"459"	"Release of eIF4E"	6	6	1	0.166666666666667	6	6	3	0.5	0.0423728813559322	5	5	3	0	0.196877807866458	1
"467"	"vRNP Assembly"	6	6	1	0.166666666666667	6	6	3	0.5	0.0338983050847458	4	4	2	0	0.196877807866458	1
"22"	"VEGFR2 mediated cell proliferation"	32	32	17	0.53125	32	32	15	0.46875	0.271186440677966	32	35	7	0	0.203261586902672	1
"347"	"Signaling by Robo receptor"	32	32	7	0.21875	32	32	15	0.46875	0.271186440677966	32	41	8	0	0.203261586902672	1
"804"	"Pre-NOTCH Transcription and Translation"	41	41	2	0.0487804878048781	41	41	19	0.463414634146341	0.864406779661017	102	156	87	0	0.204624461071248	1
"25"	"Ephrin signaling"	19	19	10	0.526315789473684	19	19	9	0.473684210526316	0.127118644067797	15	16	5	0	0.217803639574953	1
"237"	"Insulin receptor signalling cascade"	92	92	26	0.282608695652174	92	92	41	0.445652173913043	0.440677966101695	52	78	20	0	0.224168594389803	1
"313"	"Hedgehog 'off' state"	99	99	24	0.242424242424242	99	99	44	0.444444444444444	0.415254237288136	49	75	7	0	0.225320448107224	1
"583"	"Cell surface interactions at the vascular wall"	99	99	12	0.121212121212121	99	99	44	0.444444444444444	0.5	59	91	20	0	0.225320448107224	1
"784"	"Activation of ATR in response to replication stress"	37	37	2	0.0540540540540541	37	37	17	0.459459459459459	0.169491525423729	20	25	4	0	0.225944171231073	1
"721"	"Fatty acid, triacylglycerol, and ketone body metabolism"	181	181	14	0.0773480662983425	181	181	79	0.43646408839779	0.593220338983051	70	134	7	0	0.229575658585199	1
"50"	"activated TAK1 mediates p38 MAPK activation"	17	17	8	0.470588235294118	17	17	8	0.470588235294118	0.0847457627118644	10	10	2	0	0.230104311673835	1
"793"	"Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds"	97	97	5	0.0515463917525773	97	97	43	0.443298969072165	0.364406779661017	43	61	3	0	0.233949884244478	1
"112"	"VEGFR2 mediated vascular permeability"	26	26	10	0.384615384615385	26	26	12	0.461538461538462	0.161016949152542	19	24	5	0	0.237994006865531	1
"928"	"Cargo trafficking to the periciliary membrane"	51	51	1	0.0196078431372549	51	51	23	0.450980392156863	0.23728813559322	28	39	6	0	0.240086656316239	1
"213"	"IRS-related events"	88	88	26	0.295454545454545	88	88	39	0.443181818181818	0.432203389830508	51	76	20	0	0.242177617229273	1
"402"	"Synthesis of bile acids and bile salts via 27-hydroxycholesterol"	15	15	3	0.2	15	15	7	0.466666666666667	0.0677966101694915	8	8	2	0	0.243536242561716	1
"817"	"Transcriptional regulation of pluripotent stem cells"	42	42	2	0.0476190476190476	42	42	19	0.452380952380952	0.169491525423729	20	22	2	0	0.245906669595843	1
"902"	"tRNA Aminoacylation"	42	42	1	0.0238095238095238	42	42	19	0.452380952380952	0.161016949152542	19	22	2	0	0.245906669595843	1
"888"	"Transcription of the HIV genome"	65	65	2	0.0307692307692308	65	65	29	0.446153846153846	0.296610169491525	35	42	4	0	0.247286748978848	1
"358"	"E2F mediated regulation of DNA replication"	33	33	7	0.212121212121212	33	33	15	0.454545454545455	0.127118644067797	15	17	2	0	0.250354808352997	1
"768"	"Glucagon signaling in metabolic regulation"	33	33	2	0.0606060606060606	33	33	15	0.454545454545455	0.203389830508475	24	28	7	0	0.250354808352997	1
"890"	"Sialic acid metabolism"	33	33	1	0.0303030303030303	33	33	15	0.454545454545455	0.144067796610169	17	19	3	0	0.250354808352997	1
"463"	"Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"	24	24	4	0.166666666666667	24	24	11	0.458333333333333	0.101694915254237	12	14	2	0	0.2515117963265	1
"186"	"Constitutive PI3K/AKT Signaling in Cancer"	86	86	28	0.325581395348837	86	86	38	0.441860465116279	0.491525423728814	58	86	20	0	0.251743202229568	1
"636"	"Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)"	114	114	12	0.105263157894737	114	114	50	0.43859649122807	0.474576271186441	56	89	7	0	0.251976128211867	1
"325"	"Organic cation/anion/zwitterion transport"	13	13	3	0.230769230769231	13	13	6	0.461538461538462	0.076271186440678	9	10	3	0	0.258311872640015	1
"327"	"Signaling by Activin"	13	13	3	0.230769230769231	13	13	6	0.461538461538462	0.0677966101694915	8	8	3	0	0.258311872640015	1
"726"	"Initiation of Nuclear Envelope Reformation"	13	13	1	0.0769230769230769	13	13	6	0.461538461538462	0.0677966101694915	8	8	3	0	0.258311872640015	1
"728"	"Nuclear Envelope Reassembly"	13	13	1	0.0769230769230769	13	13	6	0.461538461538462	0.0677966101694915	8	8	3	0	0.258311872640015	1
"729"	"Retrograde neurotrophin signalling"	13	13	1	0.0769230769230769	13	13	6	0.461538461538462	0.0932203389830508	11	11	4	0	0.258311872640015	1
"843"	"G alpha (s) signalling events"	126	126	5	0.0396825396825397	126	126	55	0.436507936507937	0.466101694915254	55	85	7	0	0.259338057615596	1
"603"	"Loss of Function of SMAD2/3 in Cancer"	70	70	8	0.114285714285714	70	70	31	0.442857142857143	0.254237288135593	30	42	4	0	0.259948193006424	1
"604"	"Loss of Function of SMAD4 in Cancer"	70	70	8	0.114285714285714	70	70	31	0.442857142857143	0.254237288135593	30	42	4	0	0.259948193006424	1
"605"	"Loss of Function of TGFBR1 in Cancer"	70	70	8	0.114285714285714	70	70	31	0.442857142857143	0.254237288135593	30	42	4	0	0.259948193006424	1
"606"	"Loss of Function of TGFBR2 in Cancer"	70	70	8	0.114285714285714	70	70	31	0.442857142857143	0.254237288135593	30	42	4	0	0.259948193006424	1
"608"	"SMAD2/3 MH2 Domain Mutants in Cancer"	70	70	8	0.114285714285714	70	70	31	0.442857142857143	0.254237288135593	30	42	4	0	0.259948193006424	1
"609"	"SMAD2/3 Phosphorylation Motif Mutants in Cancer"	70	70	8	0.114285714285714	70	70	31	0.442857142857143	0.254237288135593	30	42	4	0	0.259948193006424	1
"610"	"SMAD4 MH2 Domain Mutants in Cancer"	70	70	8	0.114285714285714	70	70	31	0.442857142857143	0.254237288135593	30	42	4	0	0.259948193006424	1
"611"	"Signaling by TGF-beta Receptor Complex"	70	70	8	0.114285714285714	70	70	31	0.442857142857143	0.254237288135593	30	42	4	0	0.259948193006424	1
"612"	"Signaling by TGF-beta Receptor Complex in Cancer"	70	70	8	0.114285714285714	70	70	31	0.442857142857143	0.254237288135593	30	42	4	0	0.259948193006424	1
"613"	"TGFBR1 KD Mutants in Cancer"	70	70	8	0.114285714285714	70	70	31	0.442857142857143	0.254237288135593	30	42	4	0	0.259948193006424	1
"614"	"TGFBR1 LBD Mutants in Cancer"	70	70	8	0.114285714285714	70	70	31	0.442857142857143	0.254237288135593	30	42	4	0	0.259948193006424	1
"615"	"TGFBR2 Kinase Domain Mutants in Cancer"	70	70	8	0.114285714285714	70	70	31	0.442857142857143	0.254237288135593	30	42	4	0	0.259948193006424	1
"616"	"TGFBR2 MSI Frameshift Mutants in Cancer"	70	70	8	0.114285714285714	70	70	31	0.442857142857143	0.254237288135593	30	42	4	0	0.259948193006424	1
"676"	"disassembly of the destruction complex and recruitment of AXIN to the membrane"	31	31	3	0.0967741935483871	31	31	14	0.451612903225806	0.169491525423729	20	23	3	0	0.263942679571613	1
"554"	"Cell Cycle"	518	518	68	0.131274131274131	518	518	220	0.424710424710425	0.974576271186441	115	495	87	0	0.264035993496246	1
"824"	"Common Pathway"	22	22	1	0.0454545454545455	22	22	10	0.454545454545455	0.144067796610169	17	21	4	0	0.266245420222209	1
"825"	"Intrinsic Pathway"	22	22	1	0.0454545454545455	22	22	10	0.454545454545455	0.11864406779661	14	15	3	0	0.266245420222209	1
"780"	"Meiotic recombination"	54	54	3	0.0555555555555556	54	54	24	0.444444444444444	0.288135593220339	34	39	7	0	0.267225808022323	1
"342"	"PI3K Cascade"	68	68	15	0.220588235294118	68	68	30	0.441176470588235	0.364406779661017	43	59	20	0	0.270992702961707	1
"633"	"Cyclin D associated events in G1"	38	38	4	0.105263157894737	38	38	17	0.447368421052632	0.415254237288136	49	54	34	0	0.271646987876369	1
"634"	"G1 Phase"	38	38	4	0.105263157894737	38	38	17	0.447368421052632	0.415254237288136	49	54	34	0	0.271646987876369	1
"18"	"DSCAM interactions"	11	11	6	0.545454545454545	11	11	5	0.454545454545455	0.152542372881356	18	20	8	0	0.27472163721667	1
"137"	"Interleukin-6 signaling"	11	11	4	0.363636363636364	11	11	5	0.454545454545455	0.0677966101694915	8	8	3	0	0.27472163721667	1
"420"	"CYP2E1 reactions"	11	11	2	0.181818181818182	11	11	5	0.454545454545455	0.0423728813559322	5	5	1	0	0.27472163721667	1
"421"	"FGFR1c ligand binding and activation"	11	11	2	0.181818181818182	11	11	5	0.454545454545455	0.0508474576271186	6	7	2	0	0.27472163721667	1
"424"	"Recruitment of NuMA to mitotic centrosomes"	11	11	2	0.181818181818182	11	11	5	0.454545454545455	0.0677966101694915	8	9	3	0	0.27472163721667	1
"425"	"Signaling by activated point mutants of FGFR1"	11	11	2	0.181818181818182	11	11	5	0.454545454545455	0.0508474576271186	6	7	2	0	0.27472163721667	1
"379"	"SHC-mediated cascade"	29	29	6	0.206896551724138	29	29	13	0.448275862068966	0.177966101694915	21	23	7	0	0.278605127637639	1
"438"	"The role of Nef in HIV-1 replication and disease pathogenesis"	29	29	5	0.172413793103448	29	29	13	0.448275862068966	0.228813559322034	27	30	6	0	0.278605127637639	1
"545"	"YAP1- and WWTR1 (TAZ)-stimulated gene expression"	29	29	4	0.137931034482759	29	29	13	0.448275862068966	0.203389830508475	24	28	7	0	0.278605127637639	1
"862"	"PIWI-interacting RNA (piRNA) biogenesis"	29	29	1	0.0344827586206897	29	29	13	0.448275862068966	0.135593220338983	16	20	2	0	0.278605127637639	1
"705"	"Mitotic Prophase"	106	106	9	0.0849056603773585	106	106	46	0.433962264150943	0.415254237288136	49	64	4	0	0.28964944551298	1
"540"	"Transcriptional activation of mitochondrial biogenesis"	43	43	6	0.13953488372093	43	43	19	0.441860465116279	0.26271186440678	31	38	7	0	0.290219760932763	1
"159"	"AKT phosphorylates targets in the nucleus"	9	9	3	0.333333333333333	9	9	4	0.444444444444444	0.0508474576271186	6	6	2	0	0.293182644544648	1
"217"	"IRS-mediated signalling"	85	85	25	0.294117647058824	85	85	37	0.435294117647059	0.432203389830508	51	74	20	0	0.293332972007158	1
"516"	"Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"517"	"Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"518"	"Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"519"	"Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"520"	"Defective CYP19A1 causes Aromatase excess syndrome (AEXS)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"521"	"Defective CYP1B1 causes Glaucoma"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"522"	"Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"523"	"Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"524"	"Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"525"	"Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"526"	"Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"527"	"Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"528"	"Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"529"	"Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"530"	"Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"531"	"Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"532"	"Defective FMO3 causes Trimethylaminuria (TMAU)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"533"	"Defective MAOA causes Brunner syndrome (BRUNS)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"534"	"Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"535"	"Phase 1 - Functionalization of compounds"	78	78	11	0.141025641025641	78	78	34	0.435897435897436	0.296610169491525	35	47	4	0	0.294140070772404	1
"494"	"Synthesis of bile acids and bile salts"	27	27	4	0.148148148148148	27	27	12	0.444444444444444	0.127118644067797	15	17	3	0	0.294486119858498	1
"223"	"GAB1 signalosome"	104	104	30	0.288461538461538	104	104	45	0.432692307692308	0.550847457627119	65	102	20	0	0.299882792579131	1
"773"	"Global Genomic NER (GG-NER)"	34	34	2	0.0588235294117647	34	34	15	0.441176470588235	0.194915254237288	23	28	4	0	0.301102847244123	1
"582"	"Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer"	41	41	5	0.121951219512195	41	41	18	0.439024390243902	0.194915254237288	23	26	4	0	0.304762512430046	1
"7"	"Activation of NIMA Kinases NEK9, NEK6, NEK7"	7	7	5	0.714285714285714	7	7	3	0.428571428571429	0.0254237288135593	3	3	1	0	0.314335558371912	1
"70"	"MEK activation"	7	7	3	0.428571428571429	7	7	3	0.428571428571429	0.0677966101694915	8	9	7	0	0.314335558371912	1
"71"	"RAF phosphorylates MEK"	7	7	3	0.428571428571429	7	7	3	0.428571428571429	0.0677966101694915	8	9	7	0	0.314335558371912	1
"225"	"Apoptotic factor-mediated response"	7	7	2	0.285714285714286	7	7	3	0.428571428571429	0.0423728813559322	5	5	3	0	0.314335558371912	1
"228"	"FGFR3b ligand binding and activation"	7	7	2	0.285714285714286	7	7	3	0.428571428571429	0.0338983050847458	4	4	2	0	0.314335558371912	1
"499"	"Clearance of Nuclear Envelope Membranes from Chromatin"	7	7	1	0.142857142857143	7	7	3	0.428571428571429	0.0254237288135593	3	3	1	0	0.314335558371912	1
"52"	"SHC1 events in ERBB2 signaling"	32	32	15	0.46875	32	32	14	0.4375	0.220338983050847	26	31	7	0	0.317484820161855	1
"683"	"DNA strand elongation"	32	32	3	0.09375	32	32	14	0.4375	0.152542372881356	18	19	2	0	0.317484820161855	1
"761"	"Sphingolipid de novo biosynthesis"	32	32	2	0.0625	32	32	14	0.4375	0.152542372881356	18	19	3	0	0.317484820161855	1
"762"	"TGF-beta receptor signaling activates SMADs"	32	32	2	0.0625	32	32	14	0.4375	0.135593220338983	16	18	3	0	0.317484820161855	1
"886"	"Formation of the Early Elongation Complex"	32	32	1	0.03125	32	32	14	0.4375	0.152542372881356	18	18	2	0	0.317484820161855	1
"887"	"Formation of the HIV-1 Early Elongation Complex"	32	32	1	0.03125	32	32	14	0.4375	0.152542372881356	18	18	2	0	0.317484820161855	1
"32"	"JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1"	16	16	8	0.5	16	16	7	0.4375	0.0677966101694915	8	8	2	0	0.320153586165622	1
"308"	"Rap1 signalling"	16	16	4	0.25	16	16	7	0.4375	0.101694915254237	12	12	4	0	0.320153586165622	1
"895"	"Formation of Fibrin Clot (Clotting Cascade)"	39	39	1	0.0256410256410256	39	39	17	0.435897435897436	0.211864406779661	25	32	4	0	0.320256443240284	1
"956"	"Regulatory RNA pathways"	100	100	1	0.01	100	100	43	0.43	0.406779661016949	48	72	4	0	0.321393975452221	1
"349"	"FGFR ligand binding and activation"	23	23	5	0.217391304347826	23	23	10	0.434782608695652	0.110169491525424	13	14	2	0	0.330650095938276	1
"350"	"Signaling by BMP"	23	23	5	0.217391304347826	23	23	10	0.434782608695652	0.0847457627118644	10	12	3	0	0.330650095938276	1
"556"	"Downregulation of SMAD2/3:SMAD4 transcriptional activity"	23	23	3	0.130434782608696	23	23	10	0.434782608695652	0.101694915254237	12	13	2	0	0.330650095938276	1
"864"	"formation of the beta-catenin:TCF transactivating complex"	58	58	2	0.0344827586206897	58	58	25	0.431034482758621	0.406779661016949	48	62	15	0	0.334640492223607	1
"53"	"GRB2 events in ERBB2 signaling"	30	30	14	0.466666666666667	30	30	13	0.433333333333333	0.211864406779661	25	30	7	0	0.335145559167504	1
"660"	"Activation of the pre-replicative complex"	30	30	3	0.1	30	30	13	0.433333333333333	0.135593220338983	16	19	4	0	0.335145559167504	1
"191"	"G-protein beta:gamma signalling"	51	51	16	0.313725490196078	51	51	22	0.431372549019608	0.338983050847458	40	53	20	0	0.336053454243707	1
"86"	"AMPK inhibits chREBP transcriptional activation activity"	5	5	2	0.4	5	5	2	0.4	0.0169491525423729	2	2	1	0	0.339264985545963	1
"382"	"Assembly of the RAD51-ssDNA nucleoprotein complex"	5	5	1	0.2	5	5	2	0.4	0.0254237288135593	3	3	2	0	0.339264985545963	1
"392"	"RAF activation"	5	5	1	0.2	5	5	2	0.4	0.0677966101694915	8	8	7	0	0.339264985545963	1
"396"	"SMAC binds to IAPs"	5	5	1	0.2	5	5	2	0.4	0.0169491525423729	2	2	1	0	0.339264985545963	1
"397"	"SMAC-mediated apoptotic response"	5	5	1	0.2	5	5	2	0.4	0.0169491525423729	2	2	1	0	0.339264985545963	1
"398"	"SMAC-mediated dissociation of IAP:caspase complexes"	5	5	1	0.2	5	5	2	0.4	0.0169491525423729	2	2	1	0	0.339264985545963	1
"73"	"Uptake and function of anthrax toxins"	14	14	6	0.428571428571429	14	14	6	0.428571428571429	0.0508474576271186	6	7	2	0	0.342615973244063	1
"232"	"Signal attenuation"	14	14	4	0.285714285714286	14	14	6	0.428571428571429	0.0508474576271186	6	6	1	0	0.342615973244063	1
"355"	"Regulation of AMPK activity via LKB1"	14	14	3	0.214285714285714	14	14	6	0.428571428571429	0.0508474576271186	6	6	1	0	0.342615973244063	1
"500"	"FGFR1 ligand binding and activation"	14	14	2	0.142857142857143	14	14	6	0.428571428571429	0.0593220338983051	7	8	2	0	0.342615973244063	1
"501"	"Glycogen breakdown (glycogenolysis)"	14	14	2	0.142857142857143	14	14	6	0.428571428571429	0.0847457627118644	10	12	3	0	0.342615973244063	1
"791"	"DNA Repair"	115	115	6	0.0521739130434783	115	115	49	0.426086956521739	0.432203389830508	51	85	5	0	0.345539445201739	1
"218"	"IRS-related events triggered by IGF1R"	89	89	26	0.292134831460674	89	89	38	0.426966292134831	0.432203389830508	51	76	20	0	0.347685921264715	1
"33"	"MAP kinase activation in TLR cascade"	56	56	28	0.5	56	56	24	0.428571428571429	0.26271186440678	31	33	5	0	0.349283969707254	1
"440"	"Cellular Senescence"	158	158	27	0.170886075949367	158	158	67	0.424050632911392	0.906779661016949	107	211	87	0	0.350966386698558	1
"15"	"GRB2 events in EGFR signaling"	21	21	12	0.571428571428571	21	21	9	0.428571428571429	0.144067796610169	17	20	7	0	0.351427964551003	1
"813"	"Mitochondrial tRNA aminoacylation"	21	21	1	0.0476190476190476	21	21	9	0.428571428571429	0.076271186440678	9	10	2	0	0.351427964551003	1
"442"	"Amine ligand-binding receptors"	42	42	7	0.166666666666667	42	42	18	0.428571428571429	0.161016949152542	19	23	2	0	0.353382556510475	1
"806"	"Formation of HIV elongation complex in the absence of HIV Tat"	42	42	2	0.0476190476190476	42	42	18	0.428571428571429	0.194915254237288	23	24	2	0	0.353382556510475	1
"807"	"Formation of HIV-1 elongation complex containing HIV-1 Tat"	42	42	2	0.0476190476190476	42	42	18	0.428571428571429	0.186440677966102	22	24	2	0	0.353382556510475	1
"808"	"Formation of RNA Pol II elongation complex"	42	42	2	0.0476190476190476	42	42	18	0.428571428571429	0.194915254237288	23	24	2	0	0.353382556510475	1
"810"	"Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"	42	42	2	0.0476190476190476	42	42	18	0.428571428571429	0.203389830508475	24	28	4	0	0.353382556510475	1
"811"	"HIV Transcription Elongation"	42	42	2	0.0476190476190476	42	42	18	0.428571428571429	0.186440677966102	22	24	2	0	0.353382556510475	1
"815"	"RNA Polymerase II Transcription Elongation"	42	42	2	0.0476190476190476	42	42	18	0.428571428571429	0.194915254237288	23	24	2	0	0.353382556510475	1
"816"	"Tat-mediated elongation of the HIV-1 transcript"	42	42	2	0.0476190476190476	42	42	18	0.428571428571429	0.186440677966102	22	24	2	0	0.353382556510475	1
"856"	"mRNA Capping"	28	28	1	0.0357142857142857	28	28	12	0.428571428571429	0.144067796610169	17	18	2	0	0.354248594258555	1
"698"	"Factors involved in megakaryocyte development and platelet production"	125	125	11	0.088	125	125	53	0.424	0.898305084745763	106	194	87	0	0.359936249794791	1
"45"	"Interleukin-2 signaling"	47	47	23	0.48936170212766	47	47	20	0.425531914893617	0.364406779661017	43	53	20	0	0.367898353370736	1
"631"	"PPARA activates gene expression"	111	111	12	0.108108108108108	111	111	47	0.423423423423423	0.449152542372881	53	83	7	0	0.368173056450902	1
"14"	"Serotonin receptors"	12	12	7	0.583333333333333	12	12	5	0.416666666666667	0.0677966101694915	8	8	2	0	0.368374068909208	1
"445"	"FGFR3 ligand binding and activation"	12	12	2	0.166666666666667	12	12	5	0.416666666666667	0.0508474576271186	6	7	2	0	0.368374068909208	1
"446"	"FGFR3c ligand binding and activation"	12	12	2	0.166666666666667	12	12	5	0.416666666666667	0.0508474576271186	6	7	2	0	0.368374068909208	1
"460"	"Signaling by FGFR3 mutants"	12	12	2	0.166666666666667	12	12	5	0.416666666666667	0.0508474576271186	6	7	2	0	0.368374068909208	1
"461"	"Signaling by activated point mutants of FGFR3"	12	12	2	0.166666666666667	12	12	5	0.416666666666667	0.0508474576271186	6	7	2	0	0.368374068909208	1
"709"	"Death Receptor Signalling"	12	12	1	0.0833333333333333	12	12	5	0.416666666666667	0.144067796610169	17	17	12	0	0.368374068909208	1
"236"	"IGF1R signaling cascade"	92	92	26	0.282608695652174	92	92	39	0.423913043478261	0.440677966101695	52	77	20	0	0.368860709154256	1
"238"	"Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"	92	92	26	0.282608695652174	92	92	39	0.423913043478261	0.440677966101695	52	77	20	0	0.368860709154256	1
"10"	"Activation of BIM and translocation to mitochondria"	3	3	2	0.666666666666667	3	3	1	0.333333333333333	0.00847457627118644	1	1	1	0	0.37011366237799	1
"12"	"Formation of apoptosome"	3	3	2	0.666666666666667	3	3	1	0.333333333333333	0.0254237288135593	3	3	3	0	0.37011366237799	1
"167"	"Inhibition of TSC complex formation by PKB"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.0169491525423729	2	2	2	0	0.37011366237799	1
"168"	"Interactions of Tat with host cellular proteins"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.00847457627118644	1	1	1	0	0.37011366237799	1
"172"	"Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.0169491525423729	2	2	2	0	0.37011366237799	1
"173"	"Regulation of gap junction activity"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.00847457627118644	1	1	1	0	0.37011366237799	1
"175"	"STAT6-mediated induction of chemokines"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.00847457627118644	1	1	1	0	0.37011366237799	1
"177"	"TNF signaling"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.00847457627118644	1	1	1	0	0.37011366237799	1
"179"	"The NLRP1 inflammasome"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.00847457627118644	1	1	1	0	0.37011366237799	1
"181"	"betaKlotho-mediated ligand binding"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.00847457627118644	1	1	1	0	0.37011366237799	1
"182"	"c-src mediated regulation of Cx43 function and closure of gap junctions"	3	3	1	0.333333333333333	3	3	1	0.333333333333333	0.00847457627118644	1	1	1	0	0.37011366237799	1
"256"	"Purine metabolism"	33	33	9	0.272727272727273	33	33	14	0.424242424242424	0.127118644067797	15	17	3	0	0.373426496669236	1
"695"	"deactivation of the beta-catenin transactivating complex"	33	33	3	0.0909090909090909	33	33	14	0.424242424242424	0.26271186440678	31	37	15	0	0.373426496669236	1
"724"	"Downregulation of TGF-beta receptor signaling"	26	26	2	0.0769230769230769	26	26	11	0.423076923076923	0.11864406779661	14	15	3	0	0.374990983686806	1
"116"	"Signaling by Interleukins"	109	109	41	0.376146788990826	109	109	46	0.422018348623853	0.525423728813559	62	85	20	0	0.379966324619011	1
"515"	"Signaling by WNT in cancer"	212	212	30	0.141509433962264	212	212	89	0.419811320754717	0.661016949152542	78	161	15	0	0.384876432104498	1
"637"	"Transport of vitamins, nucleosides, and related molecules"	38	38	4	0.105263157894737	38	38	16	0.421052631578947	0.144067796610169	17	20	3	0	0.389529962829484	1
"877"	"Elongation arrest and recovery"	31	31	1	0.032258064516129	31	31	13	0.419354838709677	0.135593220338983	16	17	2	0	0.393783224717062	1
"878"	"HIV elongation arrest and recovery"	31	31	1	0.032258064516129	31	31	13	0.419354838709677	0.135593220338983	16	17	2	0	0.393783224717062	1
"879"	"Pausing and recovery of HIV elongation"	31	31	1	0.032258064516129	31	31	13	0.419354838709677	0.135593220338983	16	17	2	0	0.393783224717062	1
"880"	"Pausing and recovery of Tat-mediated HIV elongation"	31	31	1	0.032258064516129	31	31	13	0.419354838709677	0.127118644067797	15	17	2	0	0.393783224717062	1
"883"	"Tat-mediated HIV elongation arrest and recovery"	31	31	1	0.032258064516129	31	31	13	0.419354838709677	0.127118644067797	15	17	2	0	0.393783224717062	1
"369"	"Growth hormone receptor signaling"	24	24	5	0.208333333333333	24	24	10	0.416666666666667	0.127118644067797	15	16	2	0	0.397613272532856	1
"838"	"Cytosolic tRNA aminoacylation"	24	24	1	0.0416666666666667	24	24	10	0.416666666666667	0.101694915254237	12	12	2	0	0.397613272532856	1
"9"	"ERK1 activation"	10	10	7	0.7	10	10	4	0.4	0.0508474576271186	6	6	3	0	0.398569413718068	1
"206"	"Regulation of signaling by NODAL"	10	10	3	0.3	10	10	4	0.4	0.0508474576271186	6	6	3	0	0.398569413718068	1
"390"	"Nef Mediated CD4 Down-regulation"	10	10	2	0.2	10	10	4	0.4	0.0508474576271186	6	6	2	0	0.398569413718068	1
"670"	"Methylation"	10	10	1	0.1	10	10	4	0.4	0.0338983050847458	4	4	1	0	0.398569413718068	1
"673"	"TRIF-mediated programmed cell death"	10	10	1	0.1	10	10	4	0.4	0.161016949152542	19	20	12	0	0.398569413718068	1
"147"	"G1/S-Specific Transcription"	17	17	6	0.352941176470588	17	17	7	0.411764705882353	0.076271186440678	9	9	2	0	0.400197385713877	1
"882"	"RNA Polymerase II Pre-transcription Events"	62	62	2	0.032258064516129	62	62	26	0.419354838709677	0.288135593220339	34	37	4	0	0.402878832234118	1
"665"	"HDACs deacetylate histones"	60	60	6	0.1	60	60	25	0.416666666666667	0.203389830508475	24	31	2	0	0.419151078483331	1
"19"	"SHC1 events in EGFR signaling"	22	22	12	0.545454545454545	22	22	9	0.409090909090909	0.144067796610169	17	20	7	0	0.422413418158332	1
"255"	"Cyclin A/B1 associated events during G2/M transition"	22	22	6	0.272727272727273	22	22	9	0.409090909090909	0.0847457627118644	10	10	2	0	0.422413418158332	1
"826"	"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"	22	22	1	0.0454545454545455	22	22	9	0.409090909090909	0.101694915254237	12	12	2	0	0.422413418158332	1
"496"	"Signaling by Retinoic Acid"	41	41	6	0.146341463414634	41	41	17	0.414634146341463	0.161016949152542	19	22	3	0	0.422662235934984	1
"559"	"Signaling by Wnt"	286	286	36	0.125874125874126	286	286	119	0.416083916083916	0.73728813559322	87	210	15	0	0.425095263307422	1
"160"	"Activation of BAD and translocation to mitochondria"	15	15	5	0.333333333333333	15	15	6	0.4	0.0677966101694915	8	8	2	0	0.429310737591117	1
"281"	"CREB phosphorylation through the activation of CaMKII"	15	15	4	0.266666666666667	15	15	6	0.4	0.101694915254237	12	14	4	0	0.429310737591117	1
"551"	"Depolymerisation of the Nuclear Lamina"	15	15	2	0.133333333333333	15	15	6	0.4	0.0593220338983051	7	7	2	0	0.429310737591117	1
"745"	"HDL-mediated lipid transport"	15	15	1	0.0666666666666667	15	15	6	0.4	0.144067796610169	17	18	12	0	0.429310737591117	1
"747"	"Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)"	15	15	1	0.0666666666666667	15	15	6	0.4	0.076271186440678	9	9	2	0	0.429310737591117	1
"754"	"WNT5A-dependent internalization of FZD4"	15	15	1	0.0666666666666667	15	15	6	0.4	0.0593220338983051	7	7	2	0	0.429310737591117	1
"567"	"Ligand-receptor interactions"	8	8	1	0.125	8	8	3	0.375	0.0423728813559322	5	5	2	0	0.435121073057478	1
"573"	"Release of Hh-Np from the secreting cell"	8	8	1	0.125	8	8	3	0.375	0.0508474576271186	6	6	4	0	0.435121073057478	1
"575"	"Sema4D mediated inhibition of cell attachment and migration"	8	8	1	0.125	8	8	3	0.375	0.0847457627118644	10	11	5	0	0.435121073057478	1
"579"	"Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus"	8	8	1	0.125	8	8	3	0.375	0.0423728813559322	5	5	3	0	0.435121073057478	1
"333"	"Signaling by Insulin receptor"	116	116	26	0.224137931034483	116	116	48	0.413793103448276	0.466101694915254	55	87	20	0	0.449016850314457	1
"800"	"Fatty Acyl-CoA Biosynthesis"	20	20	1	0.05	20	20	8	0.4	0.11864406779661	14	17	6	0	0.449766707909083	1
"136"	"FRS2-mediated cascade"	44	44	16	0.363636363636364	44	44	18	0.409090909090909	0.220338983050847	26	30	7	0	0.453927258205858	1
"549"	"G2/M Checkpoints"	44	44	6	0.136363636363636	44	44	18	0.409090909090909	0.186440677966102	22	27	4	0	0.453927258205858	1
"703"	"Phospholipid metabolism"	138	138	12	0.0869565217391304	138	138	57	0.41304347826087	0.584745762711864	69	105	20	0	0.458394181796499	1
"674"	"Ca2+ pathway"	61	61	6	0.0983606557377049	61	61	25	0.409836065573771	0.245762711864407	29	38	4	0	0.462135771493076	1
"939"	"Clathrin derived vesicle budding"	61	61	1	0.0163934426229508	61	61	25	0.409836065573771	0.211864406779661	25	31	2	0	0.462135771493076	1
"940"	"trans-Golgi Network Vesicle Budding"	61	61	1	0.0163934426229508	61	61	25	0.409836065573771	0.211864406779661	25	31	2	0	0.462135771493076	1
"197"	"p75NTR recruits signalling complexes"	13	13	4	0.307692307692308	13	13	5	0.384615384615385	0.0593220338983051	7	8	2	0	0.462713094282802	1
"324"	"NF-kB is activated and signals survival"	13	13	3	0.230769230769231	13	13	5	0.384615384615385	0.0593220338983051	7	7	2	0	0.462713094282802	1
"482"	"FGFR2c ligand binding and activation"	13	13	2	0.153846153846154	13	13	5	0.384615384615385	0.0593220338983051	7	8	2	0	0.462713094282802	1
"483"	"FGFR4 ligand binding and activation"	13	13	2	0.153846153846154	13	13	5	0.384615384615385	0.0508474576271186	6	7	2	0	0.462713094282802	1
"484"	"IRF3-mediated induction of type I IFN"	13	13	2	0.153846153846154	13	13	5	0.384615384615385	0.11864406779661	14	14	5	0	0.462713094282802	1
"730"	"Trafficking and processing of endosomal TLR"	13	13	1	0.0769230769230769	13	13	5	0.384615384615385	0.0423728813559322	5	5	1	0	0.462713094282802	1
"47"	"SHC-related events"	25	25	12	0.48	25	25	10	0.4	0.144067796610169	17	18	7	0	0.465068150418511	1
"935"	"Golgi Associated Vesicle Biogenesis"	54	54	1	0.0185185185185185	54	54	22	0.407407407407407	0.186440677966102	22	28	2	0	0.472132064628458	1
"54"	"MAPK targets/ Nuclear events mediated by MAP kinases"	30	30	14	0.466666666666667	30	30	12	0.4	0.144067796610169	17	17	5	0	0.477316179850818	1
"336"	"Post-chaperonin tubulin folding pathway"	18	18	4	0.222222222222222	18	18	7	0.388888888888889	0.076271186440678	9	9	2	0	0.480154981012553	1
"620"	"Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon"	18	18	2	0.111111111111111	18	18	7	0.388888888888889	0.110169491525424	13	13	4	0	0.480154981012553	1
"44"	"p75NTR negatively regulates cell cycle via SC1"	6	6	3	0.5	6	6	2	0.333333333333333	0.0169491525423729	2	2	1	0	0.481652163225468	1
"163"	"DNA replication initiation"	6	6	2	0.333333333333333	6	6	2	0.333333333333333	0.0423728813559322	5	5	4	0	0.481652163225468	1
"171"	"Phosphorylation of Emi1"	6	6	2	0.333333333333333	6	6	2	0.333333333333333	0.0169491525423729	2	2	1	0	0.481652163225468	1
"178"	"Telomere C-strand synthesis initiation"	6	6	2	0.333333333333333	6	6	2	0.333333333333333	0.0423728813559322	5	5	4	0	0.481652163225468	1
"457"	"Pyrimidine biosynthesis"	6	6	1	0.166666666666667	6	6	2	0.333333333333333	0.0254237288135593	3	3	2	0	0.481652163225468	1
"286"	"Signaling by the B Cell Receptor (BCR)"	209	209	55	0.263157894736842	209	209	86	0.411483253588517	0.711864406779661	84	169	20	0	0.482434080645487	1
"475"	"RNF mutants show enhanced WNT signaling and proliferation"	190	190	30	0.157894736842105	190	190	78	0.410526315789474	0.652542372881356	77	148	15	0	0.491223630243398	1
"477"	"TCF dependent signaling in response to WNT"	190	190	30	0.157894736842105	190	190	78	0.410526315789474	0.652542372881356	77	148	15	0	0.491223630243398	1
"478"	"XAV939 inhibits tankyrase, stabilizing AXIN"	190	190	30	0.157894736842105	190	190	78	0.410526315789474	0.652542372881356	77	148	15	0	0.491223630243398	1
"479"	"misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling"	190	190	30	0.157894736842105	190	190	78	0.410526315789474	0.652542372881356	77	148	15	0	0.491223630243398	1
"410"	"Mitochondrial biogenesis"	52	52	10	0.192307692307692	52	52	21	0.403846153846154	0.279661016949153	33	40	7	0	0.491263793847686	1
"933"	"Synthesis of substrates in N-glycan biosythesis"	52	52	1	0.0192307692307692	52	52	21	0.403846153846154	0.203389830508475	24	27	3	0	0.491263793847686	1
"198"	"Endogenous sterols"	23	23	7	0.304347826086957	23	23	9	0.391304347826087	0.0932203389830508	11	13	3	0	0.493000589096837	1
"187"	"Interleukin-1 signaling"	40	40	13	0.325	40	40	16	0.4	0.135593220338983	16	17	2	0	0.496393762549066	1
"253"	"Negative regulation of FGFR signaling"	40	40	11	0.275	40	40	16	0.4	0.152542372881356	18	21	2	0	0.496393762549066	1
"344"	"Oxidative Stress Induced Senescence"	91	91	20	0.21978021978022	91	91	37	0.406593406593407	0.822033898305085	97	169	87	0	0.500973472351358	1
"259"	"TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling"	11	11	3	0.272727272727273	11	11	4	0.363636363636364	0.0338983050847458	4	4	1	0	0.5017758941359	1
"685"	"Androgen biosynthesis"	11	11	1	0.0909090909090909	11	11	4	0.363636363636364	0.0338983050847458	4	4	1	0	0.5017758941359	1
"692"	"Nicotinate metabolism"	11	11	1	0.0909090909090909	11	11	4	0.363636363636364	0.0423728813559322	5	5	2	0	0.5017758941359	1
"72"	"SHC1 events in ERBB4 signaling"	28	28	12	0.428571428571429	28	28	11	0.392857142857143	0.186440677966102	22	25	7	0	0.503254585117624	1
"942"	"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein"	67	67	1	0.0149253731343284	67	67	27	0.402985074626866	0.26271186440678	31	34	3	0	0.510974493341057	1
"718"	"Lipid digestion, mobilization, and transport"	50	50	4	0.08	50	50	20	0.4	0.279661016949153	33	47	12	0	0.51117102284389	1
"584"	"Metabolism of steroid hormones and vitamin D"	33	33	4	0.121212121212121	33	33	13	0.393939393939394	0.26271186440678	31	37	12	0	0.51185269364267	1
"586"	"Steroid hormones"	33	33	4	0.121212121212121	33	33	13	0.393939393939394	0.26271186440678	31	37	12	0	0.51185269364267	1
"125"	"Spry regulation of FGF signaling"	16	16	6	0.375	16	16	6	0.375	0.0593220338983051	7	7	2	0	0.514210744255391	1
"194"	"p75NTR signals via NF-kB"	16	16	5	0.3125	16	16	6	0.375	0.0677966101694915	8	9	2	0	0.514210744255391	1
"415"	"Polo-like kinase mediated events"	16	16	3	0.1875	16	16	6	0.375	0.110169491525424	13	13	7	0	0.514210744255391	1
"574"	"STING mediated induction of host immune responses"	16	16	2	0.125	16	16	6	0.375	0.127118644067797	15	15	5	0	0.514210744255391	1
"759"	"Cell-extracellular matrix interactions"	16	16	1	0.0625	16	16	6	0.375	0.110169491525424	13	13	4	0	0.514210744255391	1
"760"	"Mismatch Repair"	16	16	1	0.0625	16	16	6	0.375	0.076271186440678	9	9	2	0	0.514210744255391	1
"632"	"Collagen degradation"	38	38	4	0.105263157894737	38	38	15	0.394736842105263	0.169491525423729	20	25	6	0	0.519303200698021	1
"68"	"ERK/MAPK targets"	21	21	9	0.428571428571429	21	21	8	0.380952380952381	0.101694915254237	12	12	5	0	0.523520765427643	1
"820"	"Vasopressin regulates renal water homeostasis via Aquaporins"	43	43	2	0.0465116279069767	43	43	17	0.395348837209302	0.211864406779661	25	30	7	0	0.52591159809895	1
"287"	"Programmed Cell Death"	160	160	42	0.2625	160	160	65	0.40625	0.923728813559322	109	205	87	0	0.530813131544784	1
"487"	"Prefoldin mediated transfer of substrate  to CCT/TriC"	26	26	4	0.153846153846154	26	26	10	0.384615384615385	0.101694915254237	12	12	2	0	0.531124739355095	1
"848"	"RNA Pol II CTD phosphorylation and interaction with CE"	26	26	1	0.0384615384615385	26	26	10	0.384615384615385	0.11864406779661	14	15	2	0	0.531124739355095	1
"165"	"G beta:gamma signalling through PI3Kgamma"	48	48	16	0.333333333333333	48	48	19	0.395833333333333	0.322033898305085	38	49	20	0	0.531875321140664	1
"79"	"TRAF6 Mediated Induction of proinflammatory cytokines"	75	75	31	0.413333333333333	75	75	30	0.4	0.279661016949153	33	41	5	0	0.538554563885408	1
"29"	"Activation of PKB"	4	4	2	0.5	4	4	1	0.25	0.0169491525423729	2	2	2	0	0.546355503724712	1
"30"	"Adenosine P1 receptors"	4	4	2	0.5	4	4	1	0.25	0.00847457627118644	1	1	1	0	0.546355503724712	1
"803"	"Condensation of Prophase Chromosomes"	41	41	2	0.0487804878048781	41	41	16	0.390243902439024	0.144067796610169	17	18	2	0	0.548620260567374	1
"11"	"ERK2 activation"	9	9	6	0.666666666666667	9	9	3	0.333333333333333	0.0423728813559322	5	5	3	0	0.548671815867743	1
"62"	"G2/M DNA damage checkpoint"	9	9	4	0.444444444444444	9	9	3	0.333333333333333	0.0593220338983051	7	7	4	0	0.548671815867743	1
"65"	"Pyrimidine salvage reactions"	9	9	4	0.444444444444444	9	9	3	0.333333333333333	0.0338983050847458	4	4	2	0	0.548671815867743	1
"335"	"Formyl peptide receptors bind formyl peptides and many other ligands"	9	9	2	0.222222222222222	9	9	3	0.333333333333333	0.0508474576271186	6	6	3	0	0.548671815867743	1
"337"	"Role of Abl in Robo-Slit signaling"	9	9	2	0.222222222222222	9	9	3	0.333333333333333	0.110169491525424	13	13	8	0	0.548671815867743	1
"621"	"Gamma-carboxylation of protein precursors"	9	9	1	0.111111111111111	9	9	3	0.333333333333333	0.0423728813559322	5	5	3	0	0.548671815867743	1
"624"	"Removal of aminoterminal propeptides from gamma-carboxylated proteins"	9	9	1	0.111111111111111	9	9	3	0.333333333333333	0.0423728813559322	5	5	3	0	0.548671815867743	1
"505"	"Leading Strand Synthesis"	14	14	2	0.142857142857143	14	14	5	0.357142857142857	0.0593220338983051	7	7	2	0	0.552785935061857	1
"507"	"Polymerase switching"	14	14	2	0.142857142857143	14	14	5	0.357142857142857	0.0593220338983051	7	7	2	0	0.552785935061857	1
"508"	"Polymerase switching on the C-strand of the telomere"	14	14	2	0.142857142857143	14	14	5	0.357142857142857	0.0593220338983051	7	7	2	0	0.552785935061857	1
"739"	"Regulation of pyruvate dehydrogenase (PDH) complex"	14	14	1	0.0714285714285714	14	14	5	0.357142857142857	0.0423728813559322	5	5	1	0	0.552785935061857	1
"741"	"repression of WNT target genes"	14	14	1	0.0714285714285714	14	14	5	0.357142857142857	0.0508474576271186	6	6	2	0	0.552785935061857	1
"543"	"Gastrin-CREB signalling pathway via PKC and MAPK"	217	217	30	0.138248847926267	217	217	88	0.405529953917051	0.635593220338983	75	169	20	0	0.555141513613293	1
"476"	"Signaling by NODAL"	19	19	3	0.157894736842105	19	19	7	0.368421052631579	0.076271186440678	9	9	3	0	0.557029535636553	1
"635"	"Na+/Cl- dependent neurotransmitter transporters"	19	19	2	0.105263157894737	19	19	7	0.368421052631579	0.076271186440678	9	9	2	0	0.557029535636553	1
"148"	"Nuclear Receptor transcription pathway"	51	51	18	0.352941176470588	51	51	20	0.392156862745098	0.203389830508475	24	27	4	0	0.557824331908797	1
"844"	"Aquaporin-mediated transport"	51	51	2	0.0392156862745098	51	51	20	0.392156862745098	0.23728813559322	28	33	7	0	0.557824331908797	1
"323"	"Metabolism of nucleotides"	78	78	18	0.230769230769231	78	78	31	0.397435897435897	0.279661016949153	33	40	3	0	0.559579195333288	1
"489"	"Transcriptional regulation of white adipocyte differentiation"	78	78	12	0.153846153846154	78	78	31	0.397435897435897	0.355932203389831	42	60	7	0	0.559579195333288	1
"78"	"Nuclear Events (kinase and transcription factor activation)"	24	24	10	0.416666666666667	24	24	9	0.375	0.110169491525424	13	13	5	0	0.561134386642537	1
"370"	"Pyrimidine metabolism"	24	24	5	0.208333333333333	24	24	9	0.375	0.101694915254237	12	13	2	0	0.561134386642537	1
"924"	"Amino acid and oligopeptide SLC transporters"	49	49	1	0.0204081632653061	49	49	19	0.387755102040816	0.169491525423729	20	24	3	0	0.579012212617751	1
"100"	"MyD88 cascade initiated on plasma membrane"	86	86	34	0.395348837209302	86	86	34	0.395348837209302	0.296610169491525	35	45	5	0	0.582807285195474	1
"102"	"Toll Like Receptor 10 (TLR10) Cascade"	86	86	34	0.395348837209302	86	86	34	0.395348837209302	0.296610169491525	35	45	5	0	0.582807285195474	1
"103"	"Toll Like Receptor 5 (TLR5) Cascade"	86	86	34	0.395348837209302	86	86	34	0.395348837209302	0.296610169491525	35	45	5	0	0.582807285195474	1
"758"	"G alpha (q) signalling events"	189	189	12	0.0634920634920635	189	189	76	0.402116402116402	0.601694915254237	71	147	20	0	0.585334657964069	1
"121"	"MyD88:Mal cascade initiated on plasma membrane"	96	96	36	0.375	96	96	38	0.395833333333333	0.322033898305085	38	52	5	0	0.588706284904742	1
"126"	"Toll Like Receptor 2 (TLR2) Cascade"	96	96	36	0.375	96	96	38	0.395833333333333	0.322033898305085	38	52	5	0	0.588706284904742	1
"127"	"Toll Like Receptor TLR1:TLR2 Cascade"	96	96	36	0.375	96	96	38	0.395833333333333	0.322033898305085	38	52	5	0	0.588706284904742	1
"128"	"Toll Like Receptor TLR6:TLR2 Cascade"	96	96	36	0.375	96	96	38	0.395833333333333	0.322033898305085	38	52	5	0	0.588706284904742	1
"988"	"Diseases of glycosylation"	226	226	1	0.00442477876106195	226	226	91	0.402654867256637	0.661016949152542	78	143	6	0	0.592444789235602	1
"20"	"Signalling to p38 via RIT and RIN"	22	22	12	0.545454545454545	22	22	8	0.363636363636364	0.127118644067797	15	16	7	0	0.593518159691012	1
"39"	"SHC-mediated signalling"	22	22	11	0.5	22	22	8	0.363636363636364	0.127118644067797	15	16	7	0	0.593518159691012	1
"691"	"Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters"	22	22	2	0.0909090909090909	22	22	8	0.363636363636364	0.110169491525424	13	13	2	0	0.593518159691012	1
"13"	"RAF/MAP kinase cascade"	17	17	10	0.588235294117647	17	17	6	0.352941176470588	0.110169491525424	13	14	7	0	0.59402009523445	1
"427"	"Energy dependent regulation of mTOR by LKB1-AMPK"	17	17	3	0.176470588235294	17	17	6	0.352941176470588	0.0508474576271186	6	6	1	0	0.59402009523445	1
"591"	"Activated point mutants of FGFR2"	17	17	2	0.117647058823529	17	17	6	0.352941176470588	0.0677966101694915	8	9	2	0	0.59402009523445	1
"594"	"FGFR2 ligand binding and activation"	17	17	2	0.117647058823529	17	17	6	0.352941176470588	0.0677966101694915	8	9	2	0	0.59402009523445	1
"601"	"Platelet sensitization by LDL"	17	17	2	0.117647058823529	17	17	6	0.352941176470588	0.0932203389830508	11	11	6	0	0.59402009523445	1
"602"	"Signaling by FGFR2 mutants"	17	17	2	0.117647058823529	17	17	6	0.352941176470588	0.0677966101694915	8	9	2	0	0.59402009523445	1
"771"	"Gap-filling DNA repair synthesis and ligation in GG-NER"	17	17	1	0.0588235294117647	17	17	6	0.352941176470588	0.0932203389830508	11	12	4	0	0.59402009523445	1
"772"	"Gap-filling DNA repair synthesis and ligation in TC-NER"	17	17	1	0.0588235294117647	17	17	6	0.352941176470588	0.0932203389830508	11	12	4	0	0.59402009523445	1
"775"	"Tristetraprolin (TTP) destabilizes mRNA"	17	17	1	0.0588235294117647	17	17	6	0.352941176470588	0.0593220338983051	7	7	2	0	0.59402009523445	1
"493"	"Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding"	27	27	4	0.148148148148148	27	27	10	0.37037037037037	0.101694915254237	12	12	2	0	0.594189021271475	1
"569"	"Oncogene Induced Senescence"	32	32	4	0.125	32	32	12	0.375	0.788135593220339	93	139	87	0	0.59547439975694	1
"3"	"Reversible hydration of carbon dioxide"	12	12	11	0.916666666666667	12	12	4	0.333333333333333	0.0423728813559322	5	5	2	0	0.597062912154965	1
"6"	"ERK activation"	12	12	9	0.75	12	12	4	0.333333333333333	0.0508474576271186	6	6	3	0	0.597062912154965	1
"300"	"Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis"	12	12	3	0.25	12	12	4	0.333333333333333	0.0338983050847458	4	4	1	0	0.597062912154965	1
"302"	"NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10"	12	12	3	0.25	12	12	4	0.333333333333333	0.161016949152542	19	19	12	0	0.597062912154965	1
"455"	"P2Y receptors"	12	12	2	0.166666666666667	12	12	4	0.333333333333333	0.0423728813559322	5	5	2	0	0.597062912154965	1
"216"	"Downstream signaling events of B Cell Receptor (BCR)"	170	170	50	0.294117647058824	170	170	68	0.4	0.652542372881356	77	141	20	0	0.599692479134926	1
"503"	"Interleukin-1 processing"	7	7	1	0.142857142857143	7	7	2	0.285714285714286	0.0169491525423729	2	2	1	0	0.607139616865635	1
"506"	"Pentose phosphate pathway (hexose monophosphate shunt)"	7	7	1	0.142857142857143	7	7	2	0.285714285714286	0.0169491525423729	2	2	1	0	0.607139616865635	1
"247"	"Fc epsilon receptor (FCERI) signaling"	212	212	59	0.278301886792453	212	212	85	0.400943396226415	0.711864406779661	84	171	20	0	0.607587596375607	1
"884"	"Membrane Trafficking"	190	190	6	0.0315789473684211	190	190	76	0.4	0.610169491525424	72	129	6	0	0.608985963341631	1
"364"	"Fcgamma receptor (FCGR) dependent phagocytosis"	119	119	25	0.210084033613445	119	119	47	0.394957983193277	0.533898305084746	63	105	20	0	0.615437510491319	1
"132"	"Toll Like Receptor 9 (TLR9) Cascade"	92	92	34	0.369565217391304	92	92	36	0.391304347826087	0.313559322033898	37	47	5	0	0.619329345729621	1
"668"	"Inactivation, recovery and regulation of the phototransduction cascade"	30	30	3	0.1	30	30	11	0.366666666666667	0.127118644067797	15	18	5	0	0.62354176615382	1
"743"	"Amine compound SLC transporters"	30	30	2	0.0666666666666667	30	30	11	0.366666666666667	0.11864406779661	14	16	3	0	0.62354176615382	1
"746"	"HSF1 activation"	30	30	2	0.0666666666666667	30	30	11	0.366666666666667	0.110169491525424	13	15	2	0	0.62354176615382	1
"870"	"Lipoprotein metabolism"	30	30	1	0.0333333333333333	30	30	11	0.366666666666667	0.220338983050847	26	32	12	0	0.62354176615382	1
"717"	"Arachidonic acid metabolism"	50	50	4	0.08	50	50	19	0.38	0.186440677966102	22	28	4	0	0.624239672466991	1
"48"	"SHC-related events triggered by IGF1R"	25	25	12	0.48	25	25	9	0.36	0.144067796610169	17	18	7	0	0.625178544125222	1
"241"	"Activation of BH3-only proteins"	25	25	7	0.28	25	25	9	0.36	0.76271186440678	90	97	87	0	0.625178544125222	1
"386"	"Formation of tubulin folding intermediates by CCT/TriC"	20	20	4	0.2	20	20	7	0.35	0.076271186440678	9	9	2	0	0.628538087454866	1
"394"	"Regulation of gene expression in beta cells"	20	20	4	0.2	20	20	7	0.35	0.0847457627118644	10	10	2	0	0.628538087454866	1
"260"	"Hedgehog 'on' state"	85	85	23	0.270588235294118	85	85	33	0.388235294117647	0.322033898305085	38	51	6	0	0.633379776908026	1
"748"	"Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)"	15	15	1	0.0666666666666667	15	15	5	0.333333333333333	0.0593220338983051	7	7	2	0	0.635102733375683	1
"751"	"Regulation of innate immune responses to cytosolic DNA"	15	15	1	0.0666666666666667	15	15	5	0.333333333333333	0.0932203389830508	11	11	5	0	0.635102733375683	1
"708"	"Chaperonin-mediated protein folding"	48	48	4	0.0833333333333333	48	48	18	0.375	0.203389830508475	24	27	7	0	0.646109596650651	1
"317"	"Intrinsic Pathway for Apoptosis"	38	38	9	0.236842105263158	38	38	14	0.368421052631579	0.838983050847458	99	115	87	0	0.64784640315857	1
"4"	"Activation of the AP-1 family of transcription factors"	10	10	8	0.8	10	10	3	0.3	0.0338983050847458	4	4	2	0	0.648740083967526	1
"393"	"Regulation of Rheb GTPase activity by AMPK"	10	10	2	0.2	10	10	3	0.3	0.0254237288135593	3	3	1	0	0.648740083967526	1
"672"	"Regulated proteolysis of p75NTR"	10	10	1	0.1	10	10	3	0.3	0.0254237288135593	3	3	1	0	0.648740083967526	1
"109"	"MyD88 dependent cascade initiated on endosome"	88	88	34	0.386363636363636	88	88	34	0.386363636363636	0.305084745762712	36	45	5	0	0.650609348361734	1
"110"	"Toll Like Receptor 7/8 (TLR7/8) Cascade"	88	88	34	0.386363636363636	88	88	34	0.386363636363636	0.305084745762712	36	45	5	0	0.650609348361734	1
"855"	"Synthesis of PA"	28	28	1	0.0357142857142857	28	28	10	0.357142857142857	0.101694915254237	12	12	2	0	0.653028950547495	1
"755"	"Mitotic Prometaphase"	108	108	7	0.0648148148148148	108	108	42	0.388888888888889	0.372881355932203	44	62	4	0	0.655127718012347	1
"498"	"Cell Cycle, Mitotic"	445	445	64	0.143820224719101	445	445	179	0.402247191011236	0.889830508474576	105	321	34	0	0.656215270659337	1
"27"	"ARMS-mediated activation"	23	23	12	0.521739130434783	23	23	8	0.347826086956522	0.127118644067797	15	16	7	0	0.658136597930124	1
"557"	"Telomere C-strand (Lagging Strand) Synthesis"	23	23	3	0.130434782608696	23	23	8	0.347826086956522	0.110169491525424	13	14	4	0	0.658136597930124	1
"832"	"BBSome-mediated cargo-targeting to cilium"	23	23	1	0.0434782608695652	23	23	8	0.347826086956522	0.0677966101694915	8	8	1	0	0.658136597930124	1
"941"	"Late Phase of HIV Life Cycle"	133	133	2	0.0150375939849624	133	133	52	0.390977443609023	0.432203389830508	51	78	4	0	0.661333428346467	1
"101"	"TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation"	86	86	34	0.395348837209302	86	86	33	0.383720930232558	0.296610169491525	35	44	5	0	0.666446406104695	1
"249"	"Synthesis and interconversion of nucleotide di- and triphosphates"	18	18	5	0.277777777777778	18	18	6	0.333333333333333	0.0677966101694915	8	8	3	0	0.666479713375657	1
"351"	"Cellular response to heat stress"	51	51	11	0.215686274509804	51	51	19	0.372549019607843	0.271186440677966	32	41	7	0	0.66708827927873	1
"185"	"Downstream TCR signaling"	46	46	15	0.326086956521739	46	46	17	0.369565217391304	0.296610169491525	35	43	20	0	0.668494388305636	1
"108"	"NOD1/2 Signaling Pathway"	31	31	12	0.387096774193548	31	31	11	0.354838709677419	0.194915254237288	23	24	12	0	0.67779201656488	1
"675"	"The phototransduction cascade"	31	31	3	0.0967741935483871	31	31	11	0.354838709677419	0.127118644067797	15	18	5	0	0.67779201656488	1
"21"	"AKT phosphorylates targets in the cytosol"	13	13	7	0.538461538461538	13	13	4	0.307692307692308	0.0508474576271186	6	6	2	0	0.681031548325067	1
"56"	"p38MAPK events"	13	13	6	0.461538461538462	13	13	4	0.307692307692308	0.0847457627118644	10	11	7	0	0.681031548325067	1
"196"	"Signal regulatory protein (SIRP) family interactions"	13	13	4	0.307692307692308	13	13	4	0.307692307692308	0.0593220338983051	7	7	4	0	0.681031548325067	1
"723"	"DEx/H-box helicases activate type I IFN and inflammatory cytokines production"	13	13	1	0.0769230769230769	13	13	4	0.307692307692308	0.0338983050847458	4	4	1	0	0.681031548325067	1
"183"	"TCR signaling"	64	64	21	0.328125	64	64	24	0.375	0.338983050847458	40	57	20	0	0.683952232294533	1
"74"	"Signaling by Leptin"	26	26	11	0.423076923076923	26	26	9	0.346153846153846	0.152542372881356	18	23	7	0	0.683962172106551	1
"328"	"TAK1 activates NFkB by phosphorylation and activation of IKKs complex"	26	26	6	0.230769230769231	26	26	9	0.346153846153846	0.076271186440678	9	10	2	0	0.683962172106551	1
"384"	"Cyclin B2 mediated events"	5	5	1	0.2	5	5	1	0.2	0.00847457627118644	1	1	1	0	0.684415849177211	1
"388"	"G2 Phase"	5	5	1	0.2	5	5	1	0.2	0.0169491525423729	2	2	2	0	0.684415849177211	1
"736"	"Protein folding"	54	54	4	0.0740740740740741	54	54	20	0.37037037037037	0.220338983050847	26	29	7	0	0.686554535537917	1
"250"	"Toll-Like Receptors Cascades"	144	144	40	0.277777777777778	144	144	56	0.388888888888889	0.457627118644068	54	89	12	0	0.688795919727213	1
"26"	"SOS-mediated signalling"	21	21	11	0.523809523809524	21	21	7	0.333333333333333	0.11864406779661	14	15	7	0	0.693164131779311	1
"504"	"Lagging Strand Synthesis"	21	21	3	0.142857142857143	21	21	7	0.333333333333333	0.0847457627118644	10	10	2	0	0.693164131779311	1
"680"	"Synthesis of Leukotrienes (LT) and Eoxins (EX)"	21	21	2	0.0952380952380952	21	21	7	0.333333333333333	0.101694915254237	12	13	4	0	0.693164131779311	1
"303"	"Nucleotide-like (purinergic) receptors"	16	16	4	0.25	16	16	5	0.3125	0.0508474576271186	6	6	2	0	0.70763792684786	1
"297"	"BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members"	8	8	2	0.25	8	8	2	0.25	0.0169491525423729	2	2	1	0	0.710350743150529	1
"564"	"DARPP-32 events"	24	24	3	0.125	24	24	8	0.333333333333333	0.0932203389830508	11	11	4	0	0.716337924702677	1
"295"	"Apoptosis"	148	148	38	0.256756756756757	148	148	57	0.385135135135135	0.923728813559322	109	189	87	0	0.724421607072991	1
"841"	"Nucleotide Excision Repair"	50	50	2	0.04	50	50	18	0.36	0.228813559322034	27	33	4	0	0.728054082259189	1
"852"	"Peptide hormone metabolism"	83	83	3	0.036144578313253	83	83	31	0.373493975903614	0.355932203389831	42	53	6	0	0.729011723398153	1
"688"	"Dimerization of procaspase-8"	11	11	1	0.0909090909090909	11	11	3	0.272727272727273	0.11864406779661	14	14	12	0	0.732719621014169	1
"689"	"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins"	11	11	1	0.0909090909090909	11	11	3	0.272727272727273	0.0423728813559322	5	5	3	0	0.732719621014169	1
"690"	"Heme biosynthesis"	11	11	1	0.0909090909090909	11	11	3	0.272727272727273	0.0254237288135593	3	3	1	0	0.732719621014169	1
"693"	"Regulation by c-FLIP"	11	11	1	0.0909090909090909	11	11	3	0.272727272727273	0.11864406779661	14	14	12	0	0.732719621014169	1
"865"	"HIV Life Cycle"	146	146	5	0.0342465753424658	146	146	56	0.383561643835616	0.466101694915254	55	85	4	0	0.735623273210345	1
"64"	"Prolonged ERK activation events"	27	27	12	0.444444444444444	27	27	9	0.333333333333333	0.144067796610169	17	18	7	0	0.736769907891889	1
"850"	"Attenuation phase"	27	27	1	0.037037037037037	27	27	9	0.333333333333333	0.177966101694915	21	23	7	0	0.736769907891889	1
"795"	"G alpha (i) signalling events"	236	236	12	0.0508474576271186	236	236	92	0.389830508474576	0.550847457627119	65	132	7	0	0.74218538694398	1
"439"	"HSF1-dependent transactivation"	35	35	6	0.171428571428571	35	35	12	0.342857142857143	0.211864406779661	25	28	7	0	0.745540277241365	1
"511"	"Removal of the Flap Intermediate"	14	14	2	0.142857142857143	14	14	4	0.285714285714286	0.0423728813559322	5	5	2	0	0.752279111249072	1
"514"	"TRAF3-dependent IRF activation pathway"	14	14	2	0.142857142857143	14	14	4	0.285714285714286	0.144067796610169	17	18	7	0	0.752279111249072	1
"740"	"Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"	14	14	1	0.0714285714285714	14	14	4	0.285714285714286	0.0423728813559322	5	5	2	0	0.752279111249072	1
"903"	"HIV Transcription Initiation"	43	43	1	0.0232558139534884	43	43	15	0.348837209302326	0.186440677966102	22	23	4	0	0.75490282258035	1
"905"	"RNA Polymerase II HIV Promoter Escape"	43	43	1	0.0232558139534884	43	43	15	0.348837209302326	0.186440677966102	22	23	4	0	0.75490282258035	1
"906"	"RNA Polymerase II Promoter Escape"	43	43	1	0.0232558139534884	43	43	15	0.348837209302326	0.186440677966102	22	23	4	0	0.75490282258035	1
"907"	"RNA Polymerase II Transcription Initiation"	43	43	1	0.0232558139534884	43	43	15	0.348837209302326	0.186440677966102	22	23	4	0	0.75490282258035	1
"908"	"RNA Polymerase II Transcription Initiation And Promoter Clearance"	43	43	1	0.0232558139534884	43	43	15	0.348837209302326	0.186440677966102	22	23	4	0	0.75490282258035	1
"909"	"RNA Polymerase II Transcription Pre-Initiation And Promoter Opening"	43	43	1	0.0232558139534884	43	43	15	0.348837209302326	0.186440677966102	22	23	4	0	0.75490282258035	1
"868"	"Gap junction trafficking and regulation"	30	30	1	0.0333333333333333	30	30	10	0.333333333333333	0.144067796610169	17	18	3	0	0.754990970289766	1
"869"	"Glucagon-type ligand receptors"	30	30	1	0.0333333333333333	30	30	10	0.333333333333333	0.0932203389830508	11	13	2	0	0.754990970289766	1
"873"	"Tight junction interactions"	30	30	1	0.0333333333333333	30	30	10	0.333333333333333	0.11864406779661	14	14	3	0	0.754990970289766	1
"776"	"Glucose metabolism"	69	69	4	0.0579710144927536	69	69	25	0.36231884057971	0.305084745762712	36	43	5	0	0.765608854596972	1
"46"	"Frs2-mediated activation"	25	25	12	0.48	25	25	8	0.32	0.135593220338983	16	17	7	0	0.767615076277495	1
"588"	"Cellular response to hypoxia"	25	25	3	0.12	25	25	8	0.32	0.161016949152542	19	21	7	0	0.767615076277495	1
"589"	"Regulation of Hypoxia-inducible Factor (HIF) by oxygen"	25	25	3	0.12	25	25	8	0.32	0.161016949152542	19	21	7	0	0.767615076277495	1
"428"	"KSRP destabilizes mRNA"	17	17	3	0.176470588235294	17	17	5	0.294117647058824	0.0423728813559322	5	5	1	0	0.769611289546083	1
"925"	"Muscle contraction"	49	49	1	0.0204081632653061	49	49	17	0.346938775510204	0.474576271186441	56	90	47	0	0.784165604914157	1
"448"	"Heme degradation"	6	6	1	0.166666666666667	6	6	1	0.166666666666667	0.00847457627118644	1	1	1	0	0.785797692153082	1
"450"	"IRF3 mediated activation of type 1 IFN"	6	6	1	0.166666666666667	6	6	1	0.166666666666667	0.0423728813559322	5	5	5	0	0.785797692153082	1
"462"	"Synthesis of 15-eicosatetraenoic acid derivatives"	6	6	1	0.166666666666667	6	6	1	0.166666666666667	0.00847457627118644	1	1	1	0	0.785797692153082	1
"465"	"Telomere Extension By Telomerase"	6	6	1	0.166666666666667	6	6	1	0.166666666666667	0.00847457627118644	1	1	1	0	0.785797692153082	1
"17"	"Metabolism of folate and pterines"	9	9	5	0.555555555555556	9	9	2	0.222222222222222	0.0169491525423729	2	2	1	0	0.791190206791922	1
"299"	"ERKs are inactivated"	12	12	3	0.25	12	12	3	0.25	0.0254237288135593	3	3	1	0	0.800547975443771	1
"443"	"Bile salt and organic anion SLC transporters"	12	12	2	0.166666666666667	12	12	3	0.25	0.0254237288135593	3	3	1	0	0.800547975443771	1
"711"	"Processive synthesis on the C-strand of the telomere"	12	12	1	0.0833333333333333	12	12	3	0.25	0.0338983050847458	4	4	2	0	0.800547975443771	1
"190"	"Toll Like Receptor 4 (TLR4) Cascade"	124	124	39	0.314516129032258	124	124	46	0.370967741935484	0.415254237288136	49	79	12	0	0.80353515998446	1
"348"	"S Phase"	124	124	27	0.217741935483871	124	124	46	0.370967741935484	0.398305084745763	47	68	4	0	0.80353515998446	1
"201"	"Costimulation by the CD28 family"	73	73	22	0.301369863013699	73	73	26	0.356164383561644	0.389830508474576	46	58	20	0	0.805514293984811	1
"252"	"G1/S Transition"	109	109	30	0.275229357798165	109	109	40	0.36697247706422	0.355932203389831	42	55	4	0	0.80884735243503	1
"24"	"Signalling to RAS"	34	34	18	0.529411764705882	34	34	11	0.323529411764706	0.152542372881356	18	20	7	0	0.810322294657935	1
"847"	"Insulin receptor recycling"	26	26	1	0.0384615384615385	26	26	8	0.307692307692308	0.0847457627118644	10	10	2	0	0.811901907897407	1
"144"	"MyD88-independent cascade"	99	99	35	0.353535353535354	99	99	36	0.363636363636364	0.38135593220339	45	63	12	0	0.813414033665471	1
"145"	"TRIF-mediated TLR3/TLR4 signaling"	99	99	35	0.353535353535354	99	99	36	0.363636363636364	0.38135593220339	45	63	12	0	0.813414033665471	1
"146"	"Toll Like Receptor 3 (TLR3) Cascade"	99	99	35	0.353535353535354	99	99	36	0.363636363636364	0.38135593220339	45	63	12	0	0.813414033665471	1
"715"	"Metabolism of lipids and lipoproteins"	569	569	46	0.0808435852372583	569	569	224	0.393673110720562	0.889830508474576	105	385	20	0	0.817272157003651	1
"781"	"Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha"	18	18	1	0.0555555555555556	18	18	5	0.277777777777778	0.0508474576271186	6	6	2	0	0.821177077631296	1
"544"	"Extension of Telomeres"	29	29	4	0.137931034482759	29	29	9	0.310344827586207	0.11864406779661	14	15	4	0	0.82355567944519	1
"158"	"Activated TLR4 signalling"	115	115	39	0.339130434782609	115	115	42	0.365217391304348	0.415254237288136	49	69	12	0	0.826993435631471	1
"875"	"Diseases associated with visual transduction"	92	92	3	0.0326086956521739	92	92	33	0.358695652173913	0.406779661016949	48	73	10	0	0.828440878947911	1
"876"	"Visual phototransduction"	92	92	3	0.0326086956521739	92	92	33	0.358695652173913	0.406779661016949	48	73	10	0	0.828440878947911	1
"510"	"Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"	21	21	3	0.142857142857143	21	21	6	0.285714285714286	0.135593220338983	16	17	9	0	0.831119441297109	1
"677"	"Aflatoxin activation and detoxification"	21	21	2	0.0952380952380952	21	21	6	0.285714285714286	0.0508474576271186	6	6	1	0	0.831119441297109	1
"678"	"Defective ACY1 causes encephalopathy"	21	21	2	0.0952380952380952	21	21	6	0.285714285714286	0.0508474576271186	6	6	1	0	0.831119441297109	1
"638"	"Defective AMN causes hereditary megaloblastic anemia 1"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"639"	"Defective BTD causes biotidinase deficiency"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"640"	"Defective CD320 causes methylmalonic aciduria"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"641"	"Defective CUBN causes hereditary megaloblastic anemia 1"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"642"	"Defective GIF causes intrinsic factor deficiency"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"643"	"Defective HLCS causes multiple carboxylase deficiency"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"644"	"Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"645"	"Defective MMAA causes methylmalonic aciduria type cblA"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"646"	"Defective MMAB causes methylmalonic aciduria type cblB"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"647"	"Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"648"	"Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"649"	"Defective MTR causes methylmalonic aciduria and homocystinuria type cblG"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"650"	"Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"651"	"Defective MUT causes methylmalonic aciduria mut type"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"652"	"Defective TCN2 causes hereditary megaloblastic anemia"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"653"	"Defects in biotin (Btn) metabolism"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"654"	"Defects in cobalamin (B12) metabolism"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"655"	"Defects in vitamin and cofactor metabolism"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"656"	"Metabolism of vitamins and cofactors"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"657"	"Metabolism of water-soluble vitamins and cofactors"	87	87	9	0.103448275862069	87	87	31	0.35632183908046	0.389830508474576	46	60	12	0	0.831727394732754	1
"403"	"Uptake and actions of bacterial toxins"	40	40	8	0.2	40	40	13	0.325	0.11864406779661	14	15	2	0	0.832893829514031	1
"414"	"Activation of Matrix Metalloproteinases"	32	32	6	0.1875	32	32	10	0.3125	0.101694915254237	12	13	2	0	0.834257341984974	1
"802"	"Resolution of Sister Chromatid Cohesion"	100	100	5	0.05	100	100	36	0.36	0.347457627118644	41	54	4	0	0.834346770480132	1
"733"	"Biological oxidations"	174	174	13	0.0747126436781609	174	174	65	0.373563218390805	0.474576271186441	56	97	6	0	0.835984786024639	1
"357"	"Role of LAT2/NTAL/LAB on calcium mobilization"	141	141	30	0.212765957446809	141	141	52	0.368794326241135	0.593220338983051	70	114	20	0	0.836016127688198	1
"495"	"Regulation of actin dynamics for phagocytic cup formation"	95	95	14	0.147368421052632	95	95	34	0.357894736842105	0.398305084745763	47	65	5	0	0.837298033662601	1
"904"	"Pyruvate metabolism and Citric Acid (TCA) cycle"	43	43	1	0.0232558139534884	43	43	14	0.325581395348837	0.135593220338983	16	16	2	0	0.842852492671829	1
"706"	"Organelle biogenesis and maintenance"	323	323	27	0.0835913312693498	323	323	124	0.38390092879257	0.76271186440678	90	205	7	0	0.843817458585817	1
"984"	"Post-translational protein modification"	278	278	2	0.00719424460431655	278	278	106	0.381294964028777	0.788135593220339	93	225	24	0	0.845116104785669	1
"87"	"Activation of PPARGC1A (PGC-1alpha) by phosphorylation"	10	10	4	0.4	10	10	2	0.2	0.0169491525423729	2	2	1	0	0.85224025943095	1
"92"	"IRAK1 recruits IKK complex"	10	10	4	0.4	10	10	2	0.2	0.0254237288135593	3	3	2	0	0.85224025943095	1
"93"	"IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation"	10	10	4	0.4	10	10	2	0.2	0.0254237288135593	3	3	2	0	0.85224025943095	1
"98"	"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation"	10	10	4	0.4	10	10	2	0.2	0.0169491525423729	2	2	1	0	0.85224025943095	1
"664"	"E2F-enabled inhibition of pre-replication complex formation"	10	10	1	0.1	10	10	2	0.2	0.0169491525423729	2	2	1	0	0.85224025943095	1
"326"	"Purine salvage"	13	13	3	0.230769230769231	13	13	3	0.230769230769231	0.0169491525423729	2	3	1	0	0.853666387496528	1
"722"	"Caspase-8 activation by cleavage"	13	13	1	0.0769230769230769	13	13	3	0.230769230769231	0.11864406779661	14	14	12	0	0.853666387496528	1
"234"	"eNOS activation"	7	7	2	0.285714285714286	7	7	1	0.142857142857143	0.00847457627118644	1	1	1	0	0.857260922268061	1
"512"	"Scavenging by Class F Receptors"	7	7	1	0.142857142857143	7	7	1	0.142857142857143	0.0508474576271186	6	6	6	0	0.857260922268061	1
"416"	"Processive synthesis on the lagging strand"	16	16	3	0.1875	16	16	4	0.25	0.0423728813559322	5	5	2	0	0.857789742612088	1
"872"	"RNA Polymerase I Promoter Opening"	30	30	1	0.0333333333333333	30	30	9	0.3	0.0932203389830508	11	11	2	0	0.857838034022901	1
"932"	"RNA Polymerase II Transcription"	104	104	2	0.0192307692307692	104	104	37	0.355769230769231	0.322033898305085	38	51	4	0	0.860993315780405	1
"284"	"Mitotic G1-G1/S phases"	135	135	36	0.266666666666667	135	135	49	0.362962962962963	0.593220338983051	70	100	34	0	0.862855872904349	1
"790"	"Synthesis of PC"	19	19	1	0.0526315789473684	19	19	5	0.263157894736842	0.0593220338983051	7	7	2	0	0.863108505588755	1
"782"	"Antiviral mechanism by IFN-stimulated genes"	73	73	4	0.0547945205479452	73	73	25	0.342465753424658	0.305084745762712	36	45	4	0	0.86524737980608	1
"783"	"ISG15 antiviral mechanism"	73	73	4	0.0547945205479452	73	73	25	0.342465753424658	0.305084745762712	36	45	4	0	0.86524737980608	1
"546"	"Cholesterol biosynthesis"	22	22	3	0.136363636363636	22	22	6	0.272727272727273	0.0508474576271186	6	6	1	0	0.868926326515202	1
"823"	"ADP signalling through P2Y purinoceptor 12"	22	22	1	0.0454545454545455	22	22	6	0.272727272727273	0.0508474576271186	6	6	1	0	0.868926326515202	1
"827"	"Pyruvate metabolism"	22	22	1	0.0454545454545455	22	22	6	0.272727272727273	0.0508474576271186	6	6	1	0	0.868926326515202	1
"828"	"Smooth Muscle Contraction"	22	22	1	0.0454545454545455	22	22	6	0.272727272727273	0.0932203389830508	11	12	4	0	0.868926326515202	1
"752"	"Telomere Maintenance"	60	60	4	0.0666666666666667	60	60	20	0.333333333333333	0.220338983050847	26	27	4	0	0.869023308038736	1
"67"	"Signalling to ERKs"	44	44	19	0.431818181818182	44	44	14	0.318181818181818	0.186440677966102	22	24	7	0	0.869560892067714	1
"911"	"Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD)"	89	89	2	0.0224719101123595	89	89	31	0.348314606741573	0.305084745762712	36	50	6	0	0.871091270209947	1
"912"	"Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD)"	89	89	2	0.0224719101123595	89	89	31	0.348314606741573	0.305084745762712	36	50	6	0	0.871091270209947	1
"913"	"Defective GGT1 causes Glutathionuria (GLUTH)"	89	89	2	0.0224719101123595	89	89	31	0.348314606741573	0.305084745762712	36	50	6	0	0.871091270209947	1
"914"	"Defective GSS causes Glutathione synthetase deficiency (GSS deficiency)"	89	89	2	0.0224719101123595	89	89	31	0.348314606741573	0.305084745762712	36	50	6	0	0.871091270209947	1
"915"	"Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD)"	89	89	2	0.0224719101123595	89	89	31	0.348314606741573	0.305084745762712	36	50	6	0	0.871091270209947	1
"916"	"Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD)"	89	89	2	0.0224719101123595	89	89	31	0.348314606741573	0.305084745762712	36	50	6	0	0.871091270209947	1
"917"	"Defective SLC35D1 causes Schneckenbecken dysplasia (SCHBCKD)"	89	89	2	0.0224719101123595	89	89	31	0.348314606741573	0.305084745762712	36	50	6	0	0.871091270209947	1
"918"	"Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency)"	89	89	2	0.0224719101123595	89	89	31	0.348314606741573	0.305084745762712	36	50	6	0	0.871091270209947	1
"919"	"Defective UGT1A1 causes hyperbilirubinemia"	89	89	2	0.0224719101123595	89	89	31	0.348314606741573	0.305084745762712	36	50	6	0	0.871091270209947	1
"920"	"Defective UGT1A4 causes hyperbilirubinemia"	89	89	2	0.0224719101123595	89	89	31	0.348314606741573	0.305084745762712	36	50	6	0	0.871091270209947	1
"921"	"Phase II conjugation"	89	89	2	0.0224719101123595	89	89	31	0.348314606741573	0.305084745762712	36	50	6	0	0.871091270209947	1
"469"	"Cellular responses to stress"	248	248	40	0.161290322580645	248	248	93	0.375	0.940677966101695	111	261	87	0	0.876214291001159	1
"967"	"Asparagine N-linked glycosylation"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"968"	"Defective ALG1 causes ALG1-CDG (CDG-1k)"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"969"	"Defective ALG11 causes ALG11-CDG (CDG-1p)"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"970"	"Defective ALG12 causes ALG12-CDG (CDG-1g)"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"971"	"Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"972"	"Defective ALG2 causes ALG2-CDG (CDG-1i)"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"973"	"Defective ALG3 causes ALG3-CDG (CDG-1d)"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"974"	"Defective ALG6 causes ALG6-CDG (CDG-1c)"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"975"	"Defective ALG8 causes ALG8-CDG (CDG-1h)"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"976"	"Defective ALG9 causes ALG9-CDG (CDG-1l)"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"977"	"Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"978"	"Defective MAN1B1 causes MRT15"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"979"	"Defective MGAT2 causes MGAT2-CDG (CDG-2a)"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"980"	"Defective MOGS causes MOGS-CDG (CDG-2b)"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"981"	"Defective MPDU1 causes MPDU1-CDG (CDG-1f)"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"982"	"Defective RFT1 causes RFT1-CDG (CDG-1n)"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"983"	"Diseases associated with N-glycosylation of proteins"	118	118	1	0.00847457627118644	118	118	42	0.355932203389831	0.355932203389831	42	55	3	0	0.878319055753263	1
"853"	"Dual incision reaction in TC-NER"	28	28	1	0.0357142857142857	28	28	8	0.285714285714286	0.110169491525424	13	14	3	0	0.880814077023984	1
"854"	"Formation of transcription-coupled NER (TC-NER) repair complex"	28	28	1	0.0357142857142857	28	28	8	0.285714285714286	0.110169491525424	13	14	3	0	0.880814077023984	1
"432"	"beta-catenin independent WNT signaling"	144	144	25	0.173611111111111	144	144	52	0.361111111111111	0.415254237288136	49	80	5	0	0.881413664684976	1
"985"	"Processing of Capped Intron-Containing Pre-mRNA"	144	144	1	0.00694444444444444	144	144	52	0.361111111111111	0.415254237288136	49	73	4	0	0.881413664684976	1
"162"	"Cyclin A:Cdk2-associated events at S phase entry"	66	66	22	0.333333333333333	66	66	22	0.333333333333333	0.220338983050847	26	31	3	0	0.883121545118962	1
"750"	"RMTs methylate histone arginines"	45	45	3	0.0666666666666667	45	45	14	0.311111111111111	0.186440677966102	22	25	4	0	0.892557268676861	1
"830"	"Transcription-coupled NER (TC-NER)"	45	45	2	0.0444444444444444	45	45	14	0.311111111111111	0.194915254237288	23	26	4	0	0.892557268676861	1
"229"	"Golgi Cisternae Pericentriolar Stack Reorganization"	14	14	4	0.285714285714286	14	14	3	0.214285714285714	0.0423728813559322	5	6	3	0	0.894221297995511	1
"509"	"Regulation of IFNG signaling"	14	14	2	0.142857142857143	14	14	3	0.214285714285714	0.0423728813559322	5	5	3	0	0.894221297995511	1
"318"	"Metabolism of nitric oxide"	17	17	4	0.235294117647059	17	17	4	0.235294117647059	0.0423728813559322	5	5	2	0	0.894530764722924	1
"322"	"eNOS activation and regulation"	17	17	4	0.235294117647059	17	17	4	0.235294117647059	0.0423728813559322	5	5	2	0	0.894530764722924	1
"593"	"Butyrate Response Factor 1 (BRF1) destabilizes mRNA"	17	17	2	0.117647058823529	17	17	4	0.235294117647059	0.0338983050847458	4	4	1	0	0.894530764722924	1
"597"	"Metabolism of porphyrins"	17	17	2	0.117647058823529	17	17	4	0.235294117647059	0.0338983050847458	4	4	1	0	0.894530764722924	1
"248"	"Removal of licensing factors from origins"	72	72	20	0.277777777777778	72	72	24	0.333333333333333	0.245762711864407	29	31	3	0	0.895466721001023	1
"910"	"Glycerophospholipid biosynthesis"	88	88	2	0.0227272727272727	88	88	30	0.340909090909091	0.271186440677966	32	38	2	0	0.897661871612871	1
"474"	"Senescence-Associated Secretory Phenotype (SASP)"	75	75	12	0.16	75	75	25	0.333333333333333	0.457627118644068	54	65	34	0	0.901068738114543	1
"345"	"PCP/CE pathway"	91	91	20	0.21978021978022	91	91	31	0.340659340659341	0.288135593220339	34	46	5	0	0.903024831173867	1
"296"	"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways"	51	51	13	0.254901960784314	51	51	16	0.313725490196078	0.254237288135593	30	34	12	0	0.903665117467374	1
"230"	"Orc1 removal from chromatin"	70	70	20	0.285714285714286	70	70	23	0.328571428571429	0.23728813559322	28	30	3	0	0.906229619662759	1
"233"	"Switching of origins to a post-replicative state"	70	70	20	0.285714285714286	70	70	23	0.328571428571429	0.23728813559322	28	30	3	0	0.906229619662759	1
"35"	"Neurotransmitter Clearance In The Synaptic Cleft"	8	8	4	0.5	8	8	1	0.125	0.0169491525423729	2	2	2	0	0.906230981973905	1
"118"	"Erythrocytes take up carbon dioxide and release oxygen"	8	8	3	0.375	8	8	1	0.125	0.0169491525423729	2	2	2	0	0.906230981973905	1
"119"	"Erythrocytes take up oxygen and release carbon dioxide"	8	8	3	0.375	8	8	1	0.125	0.0169491525423729	2	2	2	0	0.906230981973905	1
"123"	"O2/CO2 exchange in erythrocytes"	8	8	3	0.375	8	8	1	0.125	0.0169491525423729	2	2	2	0	0.906230981973905	1
"566"	"Host Interactions with Influenza Factors"	8	8	1	0.125	8	8	1	0.125	0.0169491525423729	2	2	2	0	0.906230981973905	1
"572"	"Regulation of cytoskeletal remodeling and cell spreading by IPP complex components"	8	8	1	0.125	8	8	1	0.125	0.0169491525423729	2	2	2	0	0.906230981973905	1
"819"	"Iron uptake and transport"	43	43	2	0.0465116279069767	43	43	13	0.302325581395349	0.127118644067797	15	17	2	0	0.907518521585668	1
"763"	"TRAF6 mediated IRF7 activation"	32	32	2	0.0625	32	32	9	0.28125	0.177966101694915	21	24	7	0	0.910383466635428	1
"885"	"DNA methylation"	32	32	1	0.03125	32	32	9	0.28125	0.0932203389830508	11	11	2	0	0.910383466635428	1
"152"	"p53-Dependent G1 DNA Damage Response"	57	57	20	0.350877192982456	57	57	18	0.315789473684211	0.830508474576271	98	111	87	0	0.913498223873012	1
"153"	"p53-Dependent G1/S DNA damage checkpoint"	57	57	20	0.350877192982456	57	57	18	0.315789473684211	0.830508474576271	98	111	87	0	0.913498223873012	1
"796"	"Gene Expression"	1164	1164	59	0.0506872852233677	1164	1164	458	0.393470790378007	0.957627118644068	113	706	23	0	0.919792716148923	1
"822"	"Chromosome Maintenance"	87	87	4	0.0459770114942529	87	87	29	0.333333333333333	0.296610169491525	35	38	4	0	0.920305624301986	1
"837"	"Sphingolipid metabolism"	71	71	3	0.0422535211267606	71	71	23	0.323943661971831	0.228813559322034	27	30	3	0	0.920855734384481	1
"199"	"Asymmetric localization of PCP proteins"	63	63	19	0.301587301587302	63	63	20	0.317460317460317	0.177966101694915	21	27	3	0	0.922225578323135	1
"413"	"RIP-mediated NFkB activation via ZBP1"	21	21	4	0.19047619047619	21	21	5	0.238095238095238	0.0677966101694915	8	8	3	0	0.92268863178396	1
"812"	"Inflammasomes"	21	21	1	0.0476190476190476	21	21	5	0.238095238095238	0.0677966101694915	8	10	3	0	0.92268863178396	1
"580"	"M Phase"	266	266	33	0.12406015037594	266	266	98	0.368421052631579	0.652542372881356	77	151	7	0	0.923363627216316	1
"449"	"IKK complex recruitment mediated by RIP1"	24	24	4	0.166666666666667	24	24	6	0.25	0.110169491525424	13	13	4	0	0.923699998137218	1
"464"	"TRAF6 mediated NF-kB activation"	24	24	4	0.166666666666667	24	24	6	0.25	0.0677966101694915	8	9	3	0	0.923699998137218	1
"749"	"NRIF signals cell death from the nucleus"	15	15	1	0.0666666666666667	15	15	3	0.2	0.0338983050847458	4	4	2	0	0.924531842653599	1
"687"	"Cytosolic sensors of pathogen-associated DNA"	66	66	6	0.0909090909090909	66	66	21	0.318181818181818	0.296610169491525	35	47	7	0	0.926220204948995	1
"757"	"RNA Polymerase I Transcription Initiation"	47	47	3	0.0638297872340425	47	47	14	0.297872340425532	0.152542372881356	18	19	3	0	0.928685708811584	1
"285"	"Regulation of DNA replication"	75	75	20	0.266666666666667	75	75	24	0.32	0.245762711864407	29	31	3	0	0.936913567436631	1
"141"	"SCF(Skp2)-mediated degradation of p27/p21"	56	56	20	0.357142857142857	56	56	17	0.303571428571429	0.194915254237288	23	24	3	0	0.938248968255286	1
"316"	"Synthesis of DNA"	97	97	23	0.237113402061856	97	97	32	0.329896907216495	0.322033898305085	38	46	4	0	0.941873245937877	1
"470"	"Role of phospholipids in phagocytosis"	62	62	10	0.161290322580645	62	62	19	0.306451612903226	0.322033898305085	38	53	20	0	0.943954724242647	1
"756"	"Gluconeogenesis"	31	31	2	0.0645161290322581	31	31	8	0.258064516129032	0.101694915254237	12	14	5	0	0.944191869198513	1
"143"	"Cyclin E associated events during G1/S transition"	65	65	23	0.353846153846154	65	65	20	0.307692307692308	0.220338983050847	26	29	3	0	0.946614080973461	1
"261"	"Generation of second messenger molecules"	37	37	10	0.27027027027027	37	37	10	0.27027027027027	0.110169491525424	13	14	4	0	0.947011272181914	1
"861"	"Class B/2 (Secretin family receptors)"	87	87	3	0.0344827586206897	87	87	28	0.32183908045977	0.228813559322034	27	36	2	0	0.948634410653715	1
"818"	"Peptide ligand-binding receptors"	190	190	9	0.0473684210526316	190	190	67	0.352631578947368	0.491525423728814	58	95	3	0	0.948643321646476	1
"481"	"Advanced glycosylation endproduct receptor signaling"	13	13	2	0.153846153846154	13	13	2	0.153846153846154	0.0169491525423729	2	2	1	0	0.951900825709961	1
"488"	"Resolution of AP sites via the single-nucleotide replacement pathway"	13	13	2	0.153846153846154	13	13	2	0.153846153846154	0.0254237288135593	3	3	2	0	0.951900825709961	1
"133"	"G1/S DNA Damage Checkpoints"	60	60	22	0.366666666666667	60	60	18	0.3	0.830508474576271	98	111	87	0	0.951908067822373	1
"262"	"AMER1 mutants destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"263"	"APC truncation mutants are not K63 polyubiquitinated"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"264"	"APC truncation mutants have impaired AXIN binding"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"265"	"AXIN missense mutants destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"266"	"AXIN mutants destabilize the destruction complex, activating WNT signaling"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"268"	"Degradation of beta-catenin by the destruction complex"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"270"	"S33 mutants of beta-catenin aren't phosphorylated"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"271"	"S37 mutants of beta-catenin aren't phosphorylated"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"272"	"S45 mutants of beta-catenin aren't phosphorylated"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"273"	"T41 mutants of beta-catenin aren't phosphorylated"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"274"	"TCF7L2 mutants don't bind CTBP"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"275"	"deletions in the AMER1 gene destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"276"	"deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"277"	"misspliced GSK3beta mutants stabilize beta-catenin"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"278"	"phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"279"	"truncated APC mutants destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"280"	"truncations of AMER1 destabilize the destruction complex"	82	82	22	0.268292682926829	82	82	26	0.317073170731707	0.254237288135593	30	35	3	0	0.952263676606825	1
"581"	"HIV Infection"	227	227	28	0.123348017621145	227	227	81	0.356828193832599	0.627118644067797	74	131	6	0	0.952541099223865	1
"135"	"Stabilization of p53"	52	52	19	0.365384615384615	52	52	15	0.288461538461538	0.805084745762712	95	107	87	0	0.955736463693022	1
"154"	"Activation of NF-kappaB in B cells"	66	66	23	0.348484848484849	66	66	20	0.303030303030303	0.203389830508475	24	27	3	0	0.956131223118212	1
"411"	"ZBP1(DAI) mediated induction of type I IFNs"	26	26	5	0.192307692307692	26	26	6	0.230769230769231	0.101694915254237	12	13	5	0	0.95734289368182	1
"684"	"Signal amplification"	32	32	3	0.09375	32	32	8	0.25	0.0677966101694915	8	8	1	0	0.957421244114503	1
"607"	"Regulation of HSF1-mediated heat shock response"	35	35	4	0.114285714285714	35	35	9	0.257142857142857	0.11864406779661	14	15	4	0	0.958015085165401	1
"288"	"Translocation of ZAP-70 to Immunological synapse"	23	23	6	0.260869565217391	23	23	5	0.217391304347826	0.0338983050847458	4	5	1	0	0.958166410405479	1
"831"	"APC-Cdc20 mediated degradation of Nek2A"	23	23	1	0.0434782608695652	23	23	5	0.217391304347826	0.076271186440678	9	9	4	0	0.958166410405479	1
"662"	"Cobalamin (Cbl, vitamin B12) transport and metabolism"	20	20	2	0.1	20	20	4	0.2	0.135593220338983	16	16	12	0	0.959880681517631	1
"661"	"Alpha-defensins"	10	10	1	0.1	10	10	1	0.1	0.00847457627118644	1	1	1	0	0.960814653746066	1
"742"	"Class A/1 (Rhodopsin-like receptors)"	314	314	22	0.0700636942675159	314	314	114	0.363057324840764	0.593220338983051	70	149	3	0	0.96143665778801	1
"600"	"Phosphorylation of the APC/C"	17	17	2	0.117647058823529	17	17	3	0.176470588235294	0.0508474576271186	6	6	4	0	0.96285565382985	1
"734"	"Interferon alpha/beta signaling"	67	67	5	0.0746268656716418	67	67	20	0.298507462686567	0.220338983050847	26	32	3	0	0.964141933401078	1
"769"	"Negative regulators of RIG-I/MDA5 signaling"	33	33	2	0.0606060606060606	33	33	8	0.242424242424242	0.101694915254237	12	12	3	0	0.967774011956818	1
"892"	"Beta defensins"	36	36	1	0.0277777777777778	36	36	9	0.25	0.076271186440678	9	10	2	0	0.967905260499663	1
"735"	"Detoxification of Reactive Oxygen Species"	27	27	2	0.0740740740740741	27	27	6	0.222222222222222	0.076271186440678	9	9	4	0	0.968530764658862	1
"697"	"RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways"	79	79	7	0.0886075949367089	79	79	24	0.30379746835443	0.372881355932203	44	55	12	0	0.969974028287696	1
"130"	"Autodegradation of the E3 ubiquitin ligase COP1"	51	51	19	0.372549019607843	51	51	14	0.274509803921569	0.805084745762712	95	106	87	0	0.971025188518523	1
"805"	"APC/C:Cdc20 mediated degradation of Cyclin B"	21	21	1	0.0476190476190476	21	21	4	0.19047619047619	0.0677966101694915	8	8	4	0	0.971503197059403	1
"131"	"degradation of AXIN"	54	54	20	0.37037037037037	54	54	15	0.277777777777778	0.169491525423729	20	21	3	0	0.971886907857065	1
"433"	"Innate Immune System"	618	618	107	0.173139158576052	618	618	232	0.375404530744337	0.898305084745763	106	433	20	0	0.972514244534976	1
"361"	"Cell Cycle Checkpoints"	118	118	25	0.211864406779661	118	118	38	0.322033898305085	0.855932203389831	101	142	87	0	0.973612968768531	1
"778"	"Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)"	441	441	25	0.0566893424036281	441	441	162	0.36734693877551	0.73728813559322	87	222	7	0	0.97404163380216	1
"779"	"GPCR ligand binding"	441	441	25	0.0566893424036281	441	441	162	0.36734693877551	0.73728813559322	87	222	7	0	0.97404163380216	1
"422"	"Hormone ligand-binding receptors"	11	11	2	0.181818181818182	11	11	1	0.0909090909090909	0.00847457627118644	1	1	1	0	0.974982243725805	1
"686"	"Base-free sugar-phosphate removal via the single-nucleotide replacement pathway"	11	11	1	0.0909090909090909	11	11	1	0.0909090909090909	0.0169491525423729	2	2	2	0	0.974982243725805	1
"468"	"Cytokine Signaling in Immune system"	308	308	51	0.165584415584416	308	308	110	0.357142857142857	0.728813559322034	86	186	20	0	0.97541140471074	1
"965"	"mRNA Splicing"	113	113	1	0.00884955752212389	113	113	36	0.31858407079646	0.288135593220339	34	46	4	0	0.975433999860035	1
"966"	"mRNA Splicing - Major Pathway"	113	113	1	0.00884955752212389	113	113	36	0.31858407079646	0.288135593220339	34	46	4	0	0.975433999860035	1
"346"	"DNA Replication"	105	105	23	0.219047619047619	105	105	33	0.314285714285714	0.322033898305085	38	47	4	0	0.976183851253495	1
"418"	"Host Interactions of HIV factors"	135	135	25	0.185185185185185	135	135	44	0.325925925925926	0.440677966101695	52	80	6	0	0.976846961531961	1
"220"	"Regulation of mRNA stability by proteins that bind AU-rich elements"	86	86	25	0.290697674418605	86	86	26	0.302325581395349	0.26271186440678	31	36	3	0	0.977392179045172	1
"744"	"Complement cascade"	75	75	5	0.0666666666666667	75	75	22	0.293333333333333	0.288135593220339	34	43	4	0	0.978167827955176	1
"315"	"Phosphorylation of CD3 and TCR zeta chains"	25	25	6	0.24	25	25	5	0.2	0.0593220338983051	7	8	4	0	0.978173270898781	1
"473"	"Regulation of IFNA signaling"	25	25	4	0.16	25	25	5	0.2	0.0593220338983051	7	8	3	0	0.978173270898781	1
"794"	"RNA Polymerase I Transcription"	78	78	4	0.0512820512820513	78	78	23	0.294871794871795	0.203389830508475	24	29	3	0	0.979020870748515	1
"891"	"MHC class II antigen presentation"	103	103	3	0.029126213592233	103	103	32	0.310679611650485	0.364406779661017	43	60	5	0	0.979156302600707	1
"702"	"Interferon gamma signaling"	92	92	8	0.0869565217391304	92	92	28	0.304347826086957	0.330508474576271	39	43	3	0	0.979289805261666	1
"192"	"Hedgehog ligand biogenesis"	64	64	20	0.3125	64	64	18	0.28125	0.203389830508475	24	27	4	0	0.979680387431591	1
"193"	"Processing-defective Hh variants abrogate ligand secretion"	64	64	20	0.3125	64	64	18	0.28125	0.203389830508475	24	27	4	0	0.979680387431591	1
"547"	"Early Phase of HIV Life Cycle"	22	22	3	0.136363636363636	22	22	4	0.181818181818182	0.0593220338983051	7	7	4	0	0.979930756118127	1
"235"	"Assembly of the pre-replicative complex"	67	67	19	0.283582089552239	67	67	19	0.283582089552239	0.194915254237288	23	25	3	0	0.980340278766074	1
"789"	"RNA Polymerase I Promoter Clearance"	76	76	4	0.0526315789473684	76	76	22	0.289473684210526	0.203389830508475	24	28	3	0	0.982321215448145	1
"157"	"degradation of DVL"	56	56	19	0.339285714285714	56	56	15	0.267857142857143	0.220338983050847	26	28	6	0	0.982552490088693	1
"105"	"Degradation of GLI2 by the proteasome"	59	59	23	0.389830508474576	59	59	16	0.271186440677966	0.177966101694915	21	22	3	0	0.982948995846091	1
"106"	"GLI3 is processed to GLI3R by the proteasome"	59	59	23	0.389830508474576	59	59	16	0.271186440677966	0.177966101694915	21	23	3	0	0.982948995846091	1
"142"	"Degradation of GLI1 by the proteasome"	59	59	21	0.355932203389831	59	59	16	0.271186440677966	0.169491525423729	20	21	3	0	0.982948995846091	1
"267"	"DNA Replication Pre-Initiation"	82	82	22	0.268292682926829	82	82	24	0.292682926829268	0.245762711864407	29	35	4	0	0.983604785843945	1
"269"	"M/G1 Transition"	82	82	22	0.268292682926829	82	82	24	0.292682926829268	0.245762711864407	29	35	4	0	0.983604785843945	1
"444"	"Binding and entry of HIV virion"	12	12	2	0.166666666666667	12	12	1	0.0833333333333333	0.00847457627118644	1	1	1	0	0.984132424477286	1
"923"	"XBP1(S) activates chaperone genes"	48	48	1	0.0208333333333333	48	48	12	0.25	0.144067796610169	17	18	4	0	0.98593395938698	1
"149"	"AUF1 (hnRNP D0) destabilizes mRNA"	54	54	19	0.351851851851852	54	54	14	0.259259259259259	0.169491525423729	20	21	3	0	0.986164962019534	1
"150"	"SCF-beta-TrCP mediated degradation of Emi1"	54	54	19	0.351851851851852	54	54	14	0.259259259259259	0.152542372881356	18	19	3	0	0.986164962019534	1
"896"	"Glycosphingolipid metabolism"	39	39	1	0.0256410256410256	39	39	9	0.230769230769231	0.0932203389830508	11	11	2	0	0.986257245613444	1
"899"	"Transcription"	203	203	5	0.0246305418719212	203	203	68	0.334975369458128	0.457627118644068	54	89	4	0	0.986859971808573	1
"681"	"Antigen processing: Ubiquitination & Proteasome degradation"	211	211	20	0.0947867298578199	211	211	71	0.336492890995261	0.542372881355932	64	114	7	0	0.986898223856306	1
"490"	"Base Excision Repair"	20	20	3	0.15	20	20	3	0.15	0.0338983050847458	4	4	2	0	0.988016484885452	1
"491"	"Resolution of Abasic Sites (AP sites)"	20	20	3	0.15	20	20	3	0.15	0.0338983050847458	4	4	2	0	0.988016484885452	1
"311"	"Antigen processing-Cross presentation"	81	81	20	0.246913580246914	81	81	23	0.283950617283951	0.220338983050847	26	33	3	0	0.988920831391285	1
"898"	"Unfolded Protein Response (UPR)"	81	81	2	0.0246913580246914	81	81	23	0.283950617283951	0.254237288135593	30	32	4	0	0.988920831391285	1
"766"	"Metabolic disorders of biological oxidation enzymes"	614	614	38	0.0618892508143322	614	614	226	0.368078175895765	0.796610169491525	94	318	7	0	0.989293129564106	1
"155"	"Hh ligand biogenesis disease"	58	58	20	0.344827586206897	58	58	15	0.258620689655172	0.152542372881356	18	21	3	0	0.989403552356651	1
"714"	"Class I MHC mediated antigen processing & presentation"	255	255	21	0.0823529411764706	255	255	87	0.341176470588235	0.601694915254237	71	137	7	0	0.989497807675214	1
"210"	"ER-Phagosome pathway"	64	64	19	0.296875	64	64	17	0.265625	0.194915254237288	23	26	3	0	0.989712206434009	1
"897"	"PRC2 methylates histones and DNA"	40	40	1	0.025	40	40	9	0.225	0.0847457627118644	10	10	2	0	0.989775547800391	1
"774"	"Synthesis, secretion, and deacylation of Ghrelin"	17	17	1	0.0588235294117647	17	17	2	0.117647058823529	0.0169491525423729	2	2	1	0	0.990601486608224	1
"894"	"Binding and Uptake of Ligands by Scavenger Receptors"	76	76	2	0.0263157894736842	76	76	21	0.276315789473684	0.322033898305085	38	52	6	0	0.990605157186094	1
"561"	"Adaptive Immune System"	654	654	82	0.125382262996942	654	654	241	0.368501529051988	0.88135593220339	104	422	20	0	0.990880451572986	1
"881"	"RNA Polymerase I Transcription Termination"	31	31	1	0.032258064516129	31	31	6	0.193548387096774	0.0847457627118644	10	10	3	0	0.991367465800336	1
"937"	"RNA Polymerase I Chain Elongation"	56	56	1	0.0178571428571429	56	56	14	0.25	0.152542372881356	18	19	3	0	0.991775846770105	1
"96"	"Regulation of Apoptosis"	50	50	20	0.4	50	50	12	0.24	0.144067796610169	17	17	3	0	0.991852276552745	1
"343"	"FCGR activation"	50	50	11	0.22	50	50	12	0.24	0.169491525423729	20	21	4	0	0.991852276552745	1
"840"	"IRE1alpha activates chaperones"	50	50	2	0.04	50	50	12	0.24	0.144067796610169	17	18	4	0	0.991852276552745	1
"618"	"FCERI mediated Ca+2 mobilization"	62	62	7	0.112903225806452	62	62	16	0.258064516129032	0.186440677966102	22	26	4	0	0.99187027821047	1
"785"	"Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"	111	111	6	0.0540540540540541	111	111	33	0.297297297297297	0.305084745762712	36	52	3	0	0.992305324587256	1
"207"	"FCERI mediated MAPK activation"	77	77	23	0.298701298701299	77	77	21	0.272727272727273	0.271186440677966	32	40	7	0	0.992547689440621	1
"860"	"RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription"	114	114	4	0.0350877192982456	114	114	34	0.298245614035088	0.271186440677966	32	42	3	0	0.992603615804569	1
"538"	"Mitotic Anaphase"	172	172	24	0.13953488372093	172	172	55	0.319767441860465	0.474576271186441	56	83	4	0	0.992837404975722	1
"716"	"ADP signalling through P2Y purinoceptor 1"	25	25	2	0.08	25	25	4	0.16	0.0338983050847458	4	4	1	0	0.993296005462466	1
"536"	"FCERI mediated NF-kB activation"	57	57	8	0.140350877192982	57	57	14	0.245614035087719	0.186440677966102	22	23	4	0	0.993707489880846	1
"623"	"Removal of DNA patch containing abasic residue"	18	18	2	0.111111111111111	18	18	2	0.111111111111111	0.0254237288135593	3	3	2	0	0.99385854273343	1
"625"	"Resolution of AP sites via the multiple-nucleotide patch replacement pathway"	18	18	2	0.111111111111111	18	18	2	0.111111111111111	0.0254237288135593	3	3	2	0	0.99385854273343	1
"542"	"Mitotic Metaphase and Anaphase"	173	173	24	0.138728323699422	173	173	55	0.317919075144509	0.474576271186441	56	83	4	0	0.99393398447347	1
"863"	"RNA Polymerase I Promoter Escape"	29	29	1	0.0344827586206897	29	29	5	0.172413793103448	0.076271186440678	9	9	3	0	0.994568343883721	1
"893"	"Gamma carboxylation, hypusine formation and arylsulfatase activation"	36	36	1	0.0277777777777778	36	36	7	0.194444444444444	0.076271186440678	9	9	3	0	0.995169774378405	1
"184"	"CDT1 association with the CDC6:ORC:origin complex"	58	58	19	0.327586206896552	58	58	14	0.241379310344828	0.152542372881356	18	19	3	0	0.995208863435798	1
"83"	"Ubiquitin Mediated Degradation of Phosphorylated Cdc25A"	52	52	21	0.403846153846154	52	52	12	0.230769230769231	0.152542372881356	18	18	3	0	0.995379875680786	1
"84"	"p53-Independent DNA Damage Response"	52	52	21	0.403846153846154	52	52	12	0.230769230769231	0.152542372881356	18	18	3	0	0.995379875680786	1
"85"	"p53-Independent G1/S DNA damage checkpoint"	52	52	21	0.403846153846154	52	52	12	0.230769230769231	0.152542372881356	18	18	3	0	0.995379875680786	1
"113"	"Vpu mediated degradation of CD4"	52	52	20	0.384615384615385	52	52	12	0.230769230769231	0.144067796610169	17	17	3	0	0.995379875680786	1
"513"	"Separation of Sister Chromatids"	161	161	23	0.142857142857143	161	161	50	0.31055900621118	0.449152542372881	53	76	4	0	0.995469250742956	1
"82"	"Regulation of activated PAK-2p34 by proteasome mediated degradation"	49	49	20	0.408163265306122	49	49	11	0.224489795918367	0.135593220338983	16	16	3	0	0.995520405345701	1
"833"	"Defensins"	46	46	2	0.0434782608695652	46	46	10	0.217391304347826	0.0847457627118644	10	11	2	0	0.995703614166447	1
"76"	"Ubiquitin-dependent degradation of Cyclin D"	50	50	21	0.42	50	50	11	0.22	0.135593220338983	16	16	3	0	0.996678761806634	1
"77"	"Ubiquitin-dependent degradation of Cyclin D1"	50	50	21	0.42	50	50	11	0.22	0.135593220338983	16	16	3	0	0.996678761806634	1
"89"	"CDK-mediated phosphorylation and removal of Cdc6"	50	50	20	0.4	50	50	11	0.22	0.135593220338983	16	16	3	0	0.996678761806634	1
"189"	"Autodegradation of Cdh1 by Cdh1:APC/C"	60	60	19	0.316666666666667	60	60	14	0.233333333333333	0.186440677966102	22	22	4	0	0.9972610396441	1
"151"	"Vif-mediated degradation of APOBEC3G"	54	54	19	0.351851851851852	54	54	12	0.222222222222222	0.135593220338983	16	17	3	0	0.997431458792084	1
"304"	"PD-1 signaling"	28	28	7	0.25	28	28	4	0.142857142857143	0.0254237288135593	3	4	1	0	0.997882680065365	1
"732"	"Interferon Signaling"	196	196	15	0.076530612244898	196	196	61	0.311224489795918	0.516949152542373	61	97	4	0	0.998036274271371	1
"202"	"APC/C-mediated degradation of cell cycle proteins"	83	83	25	0.301204819277108	83	83	21	0.253012048192771	0.23728813559322	28	30	4	0	0.998294490731714	1
"203"	"Regulation of mitotic cell cycle"	83	83	25	0.301204819277108	83	83	21	0.253012048192771	0.23728813559322	28	30	4	0	0.998294490731714	1
"81"	"Cross-presentation of soluble exogenous antigens (endosomes)"	49	49	20	0.408163265306122	49	49	10	0.204081632653061	0.127118644067797	15	15	3	0	0.998320105277737	1
"188"	"APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1"	69	69	22	0.318840579710145	69	69	16	0.231884057971014	0.203389830508475	24	24	4	0	0.998771015630755	1
"115"	"Regulation of ornithine decarboxylase (ODC)"	50	50	19	0.38	50	50	10	0.2	0.11864406779661	14	14	3	0	0.998783048308048	1
"663"	"Creation of C4 and C2 activators"	50	50	5	0.1	50	50	10	0.2	0.152542372881356	18	18	4	0	0.998783048308048	1
"560"	"Immune System"	1216	1216	153	0.125822368421053	1216	1216	452	0.371710526315789	0.932203389830508	110	784	20	0	0.999138487367422	1
"231"	"Regulation of APC/C activators between G1/S and early anaphase"	77	77	22	0.285714285714286	77	77	18	0.233766233766234	0.220338983050847	26	27	4	0	0.999264018902236	1
"786"	"NoRC negatively regulates rRNA expression"	74	74	4	0.0540540540540541	74	74	17	0.22972972972973	0.194915254237288	23	24	3	0	0.999284746428948	1
"737"	"Chemokine receptors bind chemokines"	55	55	4	0.0727272727272727	55	55	11	0.2	0.101694915254237	12	12	2	0	0.999305790009209	1
"578"	"Thrombin signalling through proteinase activated receptors (PARs)"	32	32	4	0.125	32	32	4	0.125	0.0338983050847458	4	4	1	0	0.999574989391696	1
"200"	"Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins"	73	73	22	0.301369863013699	73	73	16	0.219178082191781	0.211864406779661	25	25	4	0	0.999617800244299	1
"204"	"APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint"	70	70	21	0.3	70	70	15	0.214285714285714	0.203389830508475	24	24	4	0	0.999638313866459	1
"699"	"Initial triggering of complement"	57	57	5	0.087719298245614	57	57	11	0.192982456140351	0.169491525423729	20	20	4	0	0.999639571773305	1
"922"	"Scavenging of heme from plasma"	47	47	1	0.0212765957446809	47	47	8	0.170212765957447	0.144067796610169	17	21	6	0	0.999658445116803	1
"713"	"Disease"	1954	1954	162	0.082906857727738	1954	1954	742	0.379733879222108	0.983050847457627	116	1261	23	0	0.999658517397758	1
"209"	"APC/C:Cdc20 mediated degradation of Securin"	64	64	19	0.296875	64	64	13	0.203125	0.177966101694915	21	21	4	0	0.999686051830945	1
"792"	"Negative epigenetic regulation of rRNA expression"	77	77	4	0.051948051948052	77	77	17	0.220779220779221	0.194915254237288	23	24	3	0	0.999701960561866	1
"617"	"Classical antibody-mediated complement activation"	44	44	5	0.113636363636364	44	44	7	0.159090909090909	0.127118644067797	15	15	4	0	0.999715565462077	1
"619"	"Metabolism of amino acids and derivatives"	188	188	21	0.111702127659574	188	188	54	0.287234042553192	0.406779661016949	48	75	3	0	0.999787487076004	1
"219"	"APC/C:Cdc20 mediated degradation of mitotic proteins"	72	72	21	0.291666666666667	72	72	15	0.208333333333333	0.203389830508475	24	24	4	0	0.999804965662341	1
"222"	"Cdc20:Phospho-APC/C mediated degradation of Cyclin A"	69	69	20	0.289855072463768	69	69	14	0.202898550724638	0.194915254237288	23	23	4	0	0.999819654560029	1
"960"	"Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"	106	106	1	0.00943396226415094	106	106	25	0.235849056603774	0.23728813559322	28	36	5	0	0.999905953259267	1
"961"	"Nonsense-Mediated Decay (NMD)"	106	106	1	0.00943396226415094	106	106	25	0.235849056603774	0.23728813559322	28	36	5	0	0.999905953259267	1
"836"	"Epigenetic regulation of gene expression"	94	94	4	0.0425531914893617	94	94	21	0.223404255319149	0.23728813559322	28	31	3	0	0.999917818049483	1
"731"	"Metabolism"	1565	1565	120	0.0766773162939297	1565	1565	577	0.368690095846645	0.966101694915254	114	941	20	0	0.999959062085838	1
"943"	"Influenza Viral RNA Transcription and Replication"	135	135	2	0.0148148148148148	135	135	30	0.222222222222222	0.288135593220339	34	44	4	0	0.999997927354116	1
"952"	"Mitochondrial translation"	92	92	1	0.0108695652173913	92	92	16	0.173913043478261	0.135593220338983	16	19	2	0	0.999999243106345	1
"949"	"Mitochondrial translation termination"	86	86	1	0.0116279069767442	86	86	14	0.162790697674419	0.127118644067797	15	17	2	0	0.999999475662408	1
"944"	"Influenza Life Cycle"	143	143	2	0.013986013986014	143	143	31	0.216783216783217	0.296610169491525	35	45	4	0	0.999999504087299	1
"951"	"Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)"	89	89	1	0.0112359550561798	89	89	14	0.157303370786517	0.144067796610169	17	19	3	0	0.999999826225869	1
"947"	"Mitochondrial translation elongation"	86	86	1	0.0116279069767442	86	86	13	0.151162790697674	0.110169491525424	13	16	2	0	0.999999862570341	1
"948"	"Mitochondrial translation initiation"	86	86	1	0.0116279069767442	86	86	13	0.151162790697674	0.11864406779661	14	16	2	0	0.999999862570341	1
"926"	"Influenza Infection"	148	148	3	0.0202702702702703	148	148	31	0.209459459459459	0.296610169491525	35	45	4	0	0.999999891953196	1
"959"	"GTP hydrolysis and joining of the 60S ribosomal subunit"	105	105	1	0.00952380952380952	105	105	18	0.171428571428571	0.186440677966102	22	26	3	0	0.999999910294321	1
"963"	"Cap-dependent Translation Initiation"	112	112	1	0.00892857142857143	112	112	20	0.178571428571429	0.194915254237288	23	29	3	0	0.999999912326731	1
"964"	"Eukaryotic Translation Initiation"	112	112	1	0.00892857142857143	112	112	20	0.178571428571429	0.194915254237288	23	29	3	0	0.999999912326731	1
"986"	"The citric acid (TCA) cycle and respiratory electron transport"	147	147	1	0.00680272108843537	147	147	30	0.204081632653061	0.254237288135593	30	35	2	0	0.999999946640317	1
"957"	"3' -UTR-mediated translational regulation"	104	104	1	0.00961538461538462	104	104	17	0.163461538461538	0.186440677966102	22	24	3	0	0.999999963807397	1
"958"	"L13a-mediated translational silencing of Ceruloplasmin expression"	104	104	1	0.00961538461538462	104	104	17	0.163461538461538	0.186440677966102	22	24	3	0	0.999999963807397	1
"934"	"Metabolism of proteins"	694	694	13	0.0187319884726225	694	694	219	0.315561959654179	0.915254237288136	108	399	24	0	0.99999997806552	1
"987"	"Translation"	148	148	1	0.00675675675675676	148	148	29	0.195945945945946	0.254237288135593	30	40	3	0	0.999999986577749	1
"954"	"Formation of a pool of free 40S subunits"	94	94	1	0.0106382978723404	94	94	13	0.138297872340426	0.127118644067797	15	17	3	0	0.999999993728637	1
"945"	"Eukaryotic Translation Termination"	84	84	1	0.0119047619047619	84	84	10	0.119047619047619	0.0847457627118644	10	11	2	0	0.999999996703129	1
"946"	"Peptide chain elongation"	84	84	1	0.0119047619047619	84	84	10	0.119047619047619	0.076271186440678	9	10	1	0	0.999999996703129	1
"950"	"Eukaryotic Translation Elongation"	89	89	1	0.0112359550561798	89	89	11	0.123595505617978	0.0847457627118644	10	11	1	0	0.999999997866786	1
"953"	"Viral mRNA Translation"	92	92	1	0.0108695652173913	92	92	11	0.119565217391304	0.0932203389830508	11	12	2	0	0.999999999379889	1
"962"	"SRP-dependent cotranslational protein targeting to membrane"	109	109	1	0.00917431192660551	109	109	15	0.137614678899083	0.11864406779661	14	16	2	0	0.999999999665107	1
"989"	"Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex"	5	5	3	0.6	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"990"	"G2/M DNA replication checkpoint"	5	5	3	0.6	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"991"	"Signalling to ERK5"	2	2	2	1	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"992"	"Dopamine clearance from the synaptic cleft"	3	3	1	0.333333333333333	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"993"	"Resolution of D-loop structures through Holliday junction intermediates"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"994"	"Activation of CaMK IV"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"995"	"Carnitine synthesis"	4	4	1	0.25	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"996"	"Resolution of D-loop structures"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"997"	"Estrogen biosynthesis"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"998"	"CREB phosphorylation through the activation of CaMKK"	4	4	2	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"999"	"Enzymatic degradation of Dopamine by monoamine oxidase"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"1000"	"Activation of BMF and translocation to mitochondria"	3	3	1	0.333333333333333	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"1001"	"NS1 Mediated Effects on Host Pathways"	4	4	1	0.25	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"1002"	"Inhibition of PKR"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"1003"	"CaMK IV-mediated phosphorylation of CREB"	3	3	1	0.333333333333333	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"1004"	"phospho-PLA2 pathway"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
"1005"	"Enzymatic degradation of dopamine by COMT"	2	2	1	0.5	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA
